endocrine neoplasm: A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.
Benign neoplasm of other and unspecified endocrine glands
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_ENDOCRINE_OTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
4941 |
4. Check minimum number of eventsNone |
4941 |
5. Include endpoints |
5100 |
6. Filter based on genotype QC (FinnGen only) |
5100 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna glandularum endocrinarum aliarum et non specificatarum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of other and unspecified endocrine glands
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26190 | 15605 | 10411 |
| Only index persons | 24177 | 14637 | 9540 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.38 | 0.45 | 0.29 |
| Only index persons | 0.47 | 0.54 | 0.36 |
| Median age at first event (years) | |||
| Whole population | 59.28 | 58.64 | 60.45 |
| Only index persons | 59.12 | 58.33 | 60.32 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5100 | 3026 | 2074 |
| Unadjusted period prevalence (%) | 0.98 | 1.03 | 0.91 |
| Median age at first event (years) | 59.31 | 57.04 | 62.62 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4502
- Matched controls
- 45017
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
2239.6
323.0
555
*
BC1AD
NOMESCO Finland
CT of adrenal glands
78.7
323.0
523
75
E23.00
ICD-10 Finland
Panhypopituitarism
239.6
323.0
333
15
H02AB09
ATC
hydrocortisone; systemic
25.8
323.0
698
318
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
+∞
323.0
2299
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
66.3
323.0
604
105
E22.1
ICD-10 Finland
Hyperprolactinaemia
54.0
323.0
395
80
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
121.9
323.0
718
70
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
11010.1
323.0
1510
*
N04BC06
ATC
cabergoline; oral (dopamine agonists)
124.7
312.2
335
29
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
642.7
307.4
301
5
101
Kela drug reimbursment
Anterior pituitary hypofunction
93.1
303.3
336
39
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
117.5
235.9
255
23
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
298.8
223.6
226
8
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
80.0
220.3
249
33
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
1984.0
207.8
200
*
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
161.5
162.7
171
11
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
7.1
142.2
368
557
ZXC86
NOMESCO Finland
Use of endoscopic device
35.9
140.8
183
53
E26.0
ICD-10 Finland
Primary hyperaldosteronism
34.0
139.0
183
56
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
162.8
135.2
142
9
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
172.5
128.1
134
8
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
13.5
121.5
217
168
102
Kela drug reimbursment
Diabetes insipidus
91.1
111.6
124
14
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
8.6
102.6
231
280
H03AA01
ATC
levothyroxine sodium; systemic
2.2
97.1
1267
6822
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
96.2
92
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
95.6
1429
8157
G02CB01
ATC
bromocriptine; systemic
7.9
92.6
221
294
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.0
91.6
397
1065
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
183.6
86.5
90
5
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
8.7
82.0
183
218
E23.05
ICD-10 Finland
Lack of TSH
42.6
77.0
96
23
H53.4
ICD-10 Finland
Visual field defects
6.4
76.9
210
339
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
76.6
870
4325
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
76.2
73
*
E21.0
ICD-10 Finland
Primary hyperparathyroidism
8.5
76.2
172
209
D35.4
ICD-10 Finland
Benign neoplasm: Pineal gland
740.3
74.4
73
*
G02CB03
ATC
cabergoline; oral (prolactine inhibitors)
23.3
72.5
105
46
XCK00
NOMESCO Finland
Perimetry
3.1
72.5
434
1494
BC4WT
NOMESCO Finland
Selective blood sample from adrenal gland with radiological guidance
146.3
68.1
72
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
67.4
468
1772
D35.9
ICD-10 Finland
Benign neoplasm: Endocrine gland, unspecified
+∞
64.7
62
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
63.8
2568
19718
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
63.2
1990
14202
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
62.9
815
4258
C03DA01
ATC
spironolactone; oral
2.4
61.7
560
2468
D35.59
ICD-10 Finland
Other paragangliom
+∞
61.6
59
*
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
22.4
60.2
88
40
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.6
60.1
219
495
N02BE01
ATC
paracetamol; systemic, rectal
2.0
59.5
3862
33962
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
57.3
1587
10806
2542
FHL
Transasal hypophysectomy
565.0
56.7
56
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
55.8
581
2733
E23.2
ICD-10 Finland
Diabetes insipidus
34.8
55.5
72
21
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
146.8
55.0
58
*
E24.8
ICD-10 Finland
Other Cushing syndrome
144.3
53.9
57
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
30.9
52.5
70
23
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
50.4
1037
6378
C08CA01
ATC
amlodipine; oral
1.7
49.8
1550
10794
BC1BD
NOMESCO Finland
Extensive CT of adrenal glands
64.1
49.3
57
9
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
171.9
48.9
51
*
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
10.3
48.4
97
96
H01AC01
ATC
somatropin; parenteral
56.7
47.5
56
10
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
7.3
47.2
116
162
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.7
46.9
213
590
J01DB01
ATC
cefalexin; oral
1.7
46.6
3600
31521
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
73.8
45.0
51
7
A02BC02
ATC
pantoprazole; systemic
1.6
44.8
2838
23430
WX110
NOMESCO Finland
Local anesthesy
1.6
43.7
2958
24737
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
35.4
43.5
56
16
C07AB07
ATC
bisoprolol; oral
1.6
42.9
1995
15232
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
42.3
808
4813
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
41.1
491
2442
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
211.9
40.9
42
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
40.8
957
6075
UJF32
NOMESCO Finland
Coloscopy
1.7
40.6
1145
7666
E260, I152
ICD-10 Finland
NA
141.3
39.8
42
*
ZXC95
NOMESCO Finland
Use of surgical navigator
6.0
39.8
113
193
BBA20
NOMESCO Finland
Exploration of parathyroid gland
18.7
39.6
61
33
A10BA02
ATC
metformin; oral
1.6
39.4
1184
8051
AA1AD
NOMESCO Finland
CT of head and brain
1.7
38.8
1026
6731
WX402
NOMESCO Finland
General anaesthesia
1.8
38.8
760
4550
22620
ICD-8 Finland
Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)
+∞
38.6
37
*
D35.50
ICD-10 Finland
Carotid body
+∞
38.6
37
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
38.1
1250
8689
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
37.9
294
1178
301
Kela drug reimbursment
Growth hormone
84.8
37.8
42
5
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
8.6
37.7
83
98
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.2
37.3
417
2010
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
+∞
36.5
35
*
R51.80
ICD-10 Finland
Headache
1.8
36.3
648
3754
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
34.5
1381
10023
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
34.3
897
5838
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
42.3
34.0
42
10
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
34.0
368
1747
N02AX02
ATC
tramadol; systemic, rectal
1.5
33.5
1779
13731
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
63.8
33.0
38
6
C03CA01
ATC
furosemide; systemic
1.6
32.6
1079
7462
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
5.2
32.6
103
201
E23.03
ICD-10 Finland
Lack of ACTH
21.6
32.1
47
22
G47.3
ICD-10 Finland
Sleep apnoea
1.6
32.0
917
6103
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
31.9
426
2210
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
31.3
1032
7116
E23.6
ICD-10 Finland
Other disorders of pituitary gland
60.4
31.1
36
6
H01CB03
ATC
lanreotide; parenteral
17.1
31.0
49
29
P01AB01
ATC
metronidazole; oral, rectal
1.5
30.0
1656
12792
E66.8
ICD-10 Finland
Other obesity
2.5
29.9
254
1069
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
29.8
387
1982
2370A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct
+∞
29.2
28
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
29.1
426
2285
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.2
28.0
300
1413
T90
ICPC
Diabetes non-insulin dependent
1.6
28.0
963
6685
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
283.2
27.8
28
*
R06.0
ICD-10 Finland
Dyspnoea
1.5
27.5
1020
7199
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
27.5
1079
7717
2271A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Parathyroid gland
+∞
27.1
26
*
22680
ICD-8 Finland
Benign neoplasm of endocrine glands, Other specified endocrine glands
+∞
27.1
26
*
G02CB04
ATC
quinagolide; oral
38.1
27.1
34
9
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
26.8
459
2604
205
Kela drug reimbursment
Chronic hypertension
1.5
26.6
1108
8017
H01CB02
ATC
octreotide; parenteral
12.8
26.6
47
37
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
6.1
26.5
73
121
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.7
26.4
183
689
CS494
NOMESCO Finland
Other visual field testing
3.4
26.2
132
400
D35.6
ICD-10 Finland
Benign neoplasm: Aortic body and other paraganglia
+∞
26.1
25
*
E26.9
ICD-10 Finland
Hyperaldosteronism, unspecified
21.3
26.0
38
18
E21.2
ICD-10 Finland
Other hyperparathyroidism
10.7
26.0
50
47
J01MA02
ATC
ciprofloxacin; systemic
1.4
25.9
1572
12277
B01AB05
ATC
enoxaparin; parenteral
1.5
25.9
1258
9398
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
25.8
1662
13120
WZC30
NOMESCO Finland
Teaching
1.7
25.2
561
3456
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
4.5
25.2
91
206
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.5
24.6
89
202
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
24.6
633
4066
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
24.4
346
1833
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
6.1
24.3
67
112
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
24.1
848
5886
N03AX16
ATC
pregabalin; oral
1.5
24.0
963
6891
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
67.8
23.8
27
*
E66.00
ICD-10 Finland
Metabolic syndrome
2.2
23.8
241
1106
R03AC02
ATC
salbutamol; inhalant
1.4
23.6
2160
18054
N07BA03
ATC
varenicline; oral
2.3
23.6
228
1026
2522
FHL
Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)
33.5
23.3
30
9
R42
ICD-10 Finland
Dizziness and giddiness
1.5
23.0
862
6070
C02AC05
ATC
moxonidine; oral
2.3
23.0
210
920
2270A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Adrenal gland
+∞
22.9
22
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
22.8
859
6052
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
22.8
439
2583
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
22.6
368
2050
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
22.6
793
5495
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
22.5
350
1915
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
22.5
1499
11825
H02AB06
ATC
prednisolone; systemic
1.4
22.4
1886
15487
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
6.7
22.1
56
84
UKC02
NOMESCO Finland
Cystoscopy
1.6
22.0
617
4042
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
21.8
968
7056
JN4BD
NOMESCO Finland
Extensive body CT
1.7
21.7
453
2731
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
21.7
649
4321
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
38.8
21.7
27
7
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.4
21.6
183
768
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
21.5
1870
15402
N06AX11
ATC
mirtazapine; oral
1.4
21.5
1247
9571
H47.2
ICD-10 Finland
Optic atrophy
9.4
21.5
44
47
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
21.4
380
2179
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
21.3
329
1799
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
5.0
21.2
68
137
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
21.1
698
4762
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
21.0
487
3027
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
60.3
20.9
24
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
12.4
20.8
37
30
R03BB04
ATC
tiotropium bromide; inhalant
1.8
20.7
395
2316
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
20.6
839
6000
A10BH01
ATC
sitagliptin; oral
1.8
20.5
389
2277
C08CA13
ATC
lercanidipine; oral
1.6
20.3
522
3343
E87.6
ICD-10 Finland
Hypokalaemia
2.7
20.1
144
554
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
20.0
628
4225
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
20.0
378
2208
C10AA01
ATC
simvastatin; oral
1.4
19.8
1684
13764
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.2
19.8
106
338
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
35.9
19.8
25
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
19.8
525
3388
R53
ICD-10 Finland
Malaise and fatigue
1.5
19.8
769
5437
A02BC05
ATC
esomeprazole; systemic
1.4
19.8
1636
13314
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
19.7
476
2990
25320
ICD-8 Finland
Diseases of pituitary gland, Chromophobe adenoma, pituitary
105.5
19.6
21
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
10.6
19.3
37
35
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
19.2
906
6664
WX882
NOMESCO Finland
High dependency care
2.7
19.0
133
503
BDA10
NOMESCO Finland
Operation on carotid body
+∞
18.8
18
*
S10
ICPC
Boil/carbuncle
2.1
18.7
223
1103
G44.2
ICD-10 Finland
Tension-type headache
1.6
18.5
507
3296
C09CA01
ATC
losartan; oral
1.4
18.5
933
6946
SPAT1254
SPAT
Administration of medicine
1.6
18.3
550
3657
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.9
18.3
260
1379
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
44.2
18.2
22
5
J01FF01
ATC
clindamycin; systemic
1.4
18.2
1068
8173
E83.50
ICD-10 Finland
Hypercalcemia
4.0
18.0
72
182
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
18.0
2024
17186
N06AX21
ATC
duloxetine; oral
1.7
18.0
419
2605
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.2
18.0
69
168
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
18.0
312
1774
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
8.1
17.9
40
50
Z71.8
ICD-10 Finland
Other specified counselling
1.4
17.8
890
6609
SPAT1262
SPAT
Handing over of treatment supplies
1.5
17.8
711
5046
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
5.5
17.8
52
95
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.8
17.7
117
429
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
17.6
449
2861
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
17.6
272
1488
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
17.6
684
4823
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
17.5
465
2995
S18
ICPC
Laceration/cut
1.3
17.5
1666
13780
A02BC01
ATC
omeprazole; systemic
1.4
17.5
1081
8340
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
17.5
444
2829
SPAT1263
SPAT
Sampling
1.3
17.4
1666
13785
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
17.3
565
3829
E23.7
ICD-10 Finland
Disorder of pituitary gland, unspecified
42.1
17.3
21
5
E23.08
ICD-10 Finland
Hypopituitarism
42.1
17.3
21
5
C10AA05
ATC
atorvastatin; oral
1.3
17.2
1484
12087
N06AX16
ATC
venlafaxine; oral
1.6
17.1
529
3541
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
31.6
17.0
22
7
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
31.6
17.0
22
7
N03AX12
ATC
gabapentin; oral
1.5
16.6
608
4230
E23.0
ICD-10 Finland
Hypopituitarism
90.4
16.6
18
*
ZX120
NOMESCO Finland
Intravenous
1.7
16.5
374
2308
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
16.4
1644
13660
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
16.4
439
2834
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
3.1
16.3
89
290
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.7
16.3
114
435
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
2.7
16.2
112
423
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
16.1
600
4187
N06AB04
ATC
citalopram; systemic
1.4
16.1
826
6150
C10AA07
ATC
rosuvastatin; oral
1.4
16.0
935
7129
N05CF01
ATC
zopiclone; oral
1.3
15.8
1213
9673
AA4DM
NOMESCO Finland
Very extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
15.6
15
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
15.6
389
2465
2530A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]
85.4
15.6
17
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
15.5
201
1029
K02.1
ICD-10 Finland
Caries of dentine
1.3
15.5
2193
19066
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
15.5
1030
8017
D01
ICPC
Abdominal pain/cramps general
1.6
15.5
386
2445
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.6
15.4
109
419
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
15.2
2172
18889
N06AA09
ATC
amitriptyline; systemic
1.6
15.2
397
2546
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
15.1
940
7230
J01MA12
ATC
levofloxacin; systemic
1.4
15.1
701
5113
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
15.0
426
2791
R31
ICD-10 Finland
Unspecified haematuria
1.7
14.9
349
2170
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
14.9
1459
12038
A46
ICD-10 Finland
Erysipelas
1.5
14.9
507
3468
2533
FHL
Unilateral removal of additional egg
56.8
14.8
17
*
8700/3-C74.9
ICD-O-3
Pheochromocytoma, NOS, of adrenal gland, NOS
56.8
14.8
17
*
C09CA03
ATC
valsartan; oral
1.7
14.8
331
2035
R02
ICPC
Shortness of breath/dyspnoea
1.6
14.7
441
2924
A02BC03
ATC
lansoprazole; oral
1.3
14.7
1131
9000
M54.5
ICD-10 Finland
Low back pain
1.3
14.6
1235
9968
D352, E221
ICD-10 Finland
NA
+∞
14.6
14
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
14.5
1030
8086
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
14.5
180
906
2159
FHL
Other measure in this category
150.4
14.5
15
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
5.7
14.5
41
73
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
14.5
887
6800
A28
ICPC
Limited function/disability NOS
1.5
14.4
507
3491
ZXA10
NOMESCO Finland
Bilateral
1.4
14.4
689
5050
A11CC03
ATC
alfacalcidol; systemic
2.6
14.4
102
393
N06AB10
ATC
escitalopram; oral
1.4
14.3
724
5366
J01AA02
ATC
doxycycline; systemic
1.3
14.2
3227
29700
A02BA02
ATC
ranitidine; systemic
1.4
14.2
745
5554
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.0
14.2
180
914
R60.0
ICD-10 Finland
Localized oedema
1.6
14.2
416
2743
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
14.2
528
3680
N05AH04
ATC
quetiapine; oral
1.5
14.1
568
4023
D06
ICPC
Abdominal pain localized other
1.7
14.1
301
1826
M79.6
ICD-10 Finland
Pain in limb
1.3
14.0
1369
11267
R10.0
ICD-10 Finland
Acute abdomen
2.3
13.6
126
561
2532A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]
+∞
13.5
13
*
D35.3
ICD-10 Finland
Benign neoplasm: Craniopharyngeal duct
+∞
13.5
13
*
D35.7
ICD-10 Finland
Benign neoplasm: Other specified endocrine glands
+∞
13.5
13
*
R4110
NOMESCO Finland
Physiotherapy
1.3
13.5
1013
8009
WF002
NOMESCO Finland
Radical radiotherapy
1.9
13.5
187
981
T73
ICPC
Neoplasm endocrine other/unspecified
16.2
13.4
21
13
XA800
NOMESCO Finland
Neuropsychological investigation
2.1
13.4
150
726
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
13.4
452
3080
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
13.4
188
995
L28
ICPC
Limited function/disability (L)
1.5
13.4
558
3982
N04BC01
ATC
bromocriptine; oral
25.8
13.3
18
7
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.9
13.3
209
1152
C07AA05
ATC
propranolol; systemic
1.4
13.3
702
5236
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
3.1
13.2
71
230
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
13.2
278
1680
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
13.2
378
2480
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
13.2
1149
9289
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
13.2
811
6214
M25.5
ICD-10 Finland
Pain in joint
1.3
13.2
1064
8509
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
13.1
404
2698
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.0
13.0
51
129
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.1
12.9
148
721
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
12.9
1269
10428
TAB00
NOMESCO Finland
Lumbar puncture
2.0
12.9
172
891
2520A
ICD-9 Finland
Disorders of parathyroid gland, Hyperparathyroidism
22.6
12.9
18
8
N05BA04
ATC
oxazepam; oral
1.3
12.9
913
7151
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
12.8
293
1813
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
12.8
486
3402
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
8.5
12.7
27
32
V04CD01
ATC
metyrapone; oral
70.0
12.6
14
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
12.5
621
4578
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.0
12.4
155
784
WX725
NOMESCO Finland
Noninvasive ventilation
1.9
12.4
178
950
M48.0
ICD-10 Finland
Spinal stenosis
1.5
12.4
433
2975
R50.9
ICD-10 Finland
Fever, unspecified
1.5
12.4
482
3388
Y28
ICPC
Limited function/disability (Y)
6.9
12.4
30
44
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
12.3
570
4144
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
12.2
1053
8492
M03BX02
ATC
tizanidine; oral
1.3
12.0
2466
22150
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
12.0
1060
8570
T99
ICPC
Endocr/metab/nutrit disease other
2.9
11.9
71
248
N28.1
ICD-10 Finland
Cyst of kidney
3.0
11.9
66
220
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
11.9
342
2245
2531A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]
46.8
11.9
14
*
H47.4
ICD-10 Finland
Disorders of optic chiasm
46.8
11.9
14
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
11.9
624
4645
A12BA01
ATC
potassium chloride; oral
2.0
11.8
155
800
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
11.8
1540
13102
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
11.8
153
788
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.6
11.8
86
339
H02AA02
ATC
fludrocortisone; oral
4.1
11.8
44
107
L72.1
ICD-10 Finland
Trichilemmal cyst
1.7
11.6
220
1290
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
6.5
11.5
29
45
WX290
NOMESCO Finland
Other blockade of nerve
1.3
11.5
1618
13879
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
11.5
293
1866
E89.39
ICD-10 Finland
Postprocedural hypopituitarism, other or several procedures
+∞
11.5
11
*
S06.0
ICD-10 Finland
Concussion
1.5
11.5
363
2441
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.8
11.4
186
1040
A01
ICPC
Pain general/multiple sites
1.6
11.4
278
1751
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.5
11.3
87
353
A06AD11
ATC
lactulose; oral
1.4
11.3
480
3431
J01DA01
ATC
[U] cefalexin; systemic
1.2
11.3
2485
22414
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
6.0
11.3
30
50
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
11.3
427
2983
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
11.3
352
2356
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
11.3
136
681
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
35.1
11.3
14
*
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
11.2
354
2379
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
11.1
480
3440
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
25.1
11.1
15
6
K30
ICD-10 Finland
Functional dyspepsia
1.5
11.1
382
2617
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
11.1
376
2567
C09AA02
ATC
enalapril; systemic
1.4
11.0
701
5385
SPAT1153
SPAT
Removal of sutures
1.3
11.0
1224
10184
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.6
10.9
267
1683
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
10.9
312
2047
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
10.9
234
1426
C07AB02
ATC
metoprolol; systemic
1.3
10.8
720
5572
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
10.8
401
2788
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.4
10.7
89
375
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
10.7
176
984
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
10.6
1823
15952
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
10.6
483
3500
KH1AD
NOMESCO Finland
CT of urinary organs
2.0
10.6
131
663
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
8.0
10.6
23
29
E21
ICD-10 Finland
Hyperparathyroidism and other disorders of parathyroid gland
8.0
10.6
23
29
106
Kela drug reimbursment
Hypoparathyroidism
5.5
10.5
30
55
-50
ICPC
Medication/prescr/renewal
1.9
10.5
157
852
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.9
10.5
147
780
E27.2
ICD-10 Finland
Addisonian crisis
14.2
10.5
17
12
D35.8
ICD-10 Finland
Benign neoplasm: Pluriglandular involvement
+∞
10.4
10
*
AA4BM
NOMESCO Finland
MRI examination of sella turcica with 3 Tesla magnet
+∞
10.4
10
*
UDM02
NOMESCO Finland
Sinoscopy
2.3
10.4
93
409
J01FA10
ATC
azithromycin; systemic
1.2
10.3
2235
20032
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
10.3
273
1758
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
6.4
10.3
26
41
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
10.3
352
2408
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
10.3
726
5664
M01AE02
ATC
naproxen; oral, rectal
1.2
10.3
2187
19569
E27.0
ICD-10 Finland
Other adrenocortical overactivity
18.8
10.2
15
8
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
10.2
469
3406
E83.51
ICD-10 Finland
Hypocalcemia
4.9
10.2
32
66
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
10.2
490
3590
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
10.2
393
2757
XKD00
NOMESCO Finland
Uroflowmetry
1.4
10.1
527
3912
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
10.1
216
1314
H05BX01
ATC
cinacalcet; oral
4.4
10.1
35
80
S29
ICPC
Skin symptom/complaint other
1.4
10.1
589
4459
A04
ICPC
Weakness/tiredness general
1.4
10.1
436
3126
XG466
NOMESCO Finland
Sleep oxymetry
2.0
10.0
127
650
N20.1
ICD-10 Finland
Calculus of ureter
1.9
10.0
137
720
Z00.0
ICD-10 Finland
General medical examination
1.3
10.0
654
5038
C08CA02
ATC
felodipine; oral
1.5
10.0
327
2215
ZZC00
NOMESCO Finland
Graft of fascia
14.6
10.0
16
11
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
9.9
281
1840
R07.3
ICD-10 Finland
Other chest pain
1.5
9.9
324
2195
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
9.9
1075
8902
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
9.8
364
2532
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
9.8
504
3731
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.6
9.8
70
273
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
9.8
577
4372
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
5.4
9.8
28
52
B01AA03
ATC
warfarin; systemic
1.3
9.8
640
4933
EBA00
NOMESCO Finland
Extraction of tooth
1.3
9.8
1161
9714
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
9.8
631
4855
M01AB05
ATC
diclofenac; systemic, rectal
1.2
9.7
2661
24375
R11
ICD-10 Finland
Nausea and vomiting
1.6
9.7
273
1782
321
Kela drug reimbursment
Paricalcitol and cinacalcet
4.5
9.7
33
74
XW000
NOMESCO Finland
Bone marrow biopsy
1.9
9.7
144
779
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.2
9.7
94
431
C03AA03
ATC
hydrochlorothiazide; oral
1.5
9.7
339
2328
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
3.5
9.7
43
123
WX892
NOMESCO Finland
Monitored bed care
1.6
9.7
265
1723
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
9.6
214
1317
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
9.5
240
1527
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
9.5
666
5184
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
2.4
9.5
76
317
RD210
NOMESCO Finland
NA
2.5
9.5
70
280
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.0
9.5
122
626
N30.0
ICD-10 Finland
Acute cystitis
1.4
9.4
476
3513
N20.0
ICD-10 Finland
Calculus of kidney
2.3
9.4
84
370
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
9.4
80
342
E66.9
ICD-10 Finland
Obesity, unspecified
1.9
9.4
124
647
N05CF02
ATC
zolpidem; oral
1.3
9.4
622
4805
N75
ICPC
Benign neoplasm nervous system
12.3
9.3
16
13
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
21.7
9.3
13
6
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
5.3
9.3
27
51
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.4
9.3
43
127
D11
ICPC
Diarrhoea
1.5
9.3
357
2499
J01DA06
ATC
[U] cefuroxime; systemic
1.4
9.3
518
3887
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
9.3
2737
25201
ZXA00
NOMESCO Finland
Right side
1.3
9.3
980
8075
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
9.2
754
6002
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
9.2
377
2672
L03
ICPC
Low back symptom/complaint
1.3
9.2
861
6980
B01AC04
ATC
clopidogrel; oral
1.4
9.2
517
3886
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.8
9.2
144
796
A10AE04
ATC
insulin glargine; parenteral
1.5
9.2
317
2171
XF402
NOMESCO Finland
ECG with work load test
1.4
9.2
390
2787
N17
ICPC
Vertigo/dizziness
1.4
9.1
373
2648
N06AB03
ATC
fluoxetine; oral
1.4
9.1
435
3179
WX002
NOMESCO Finland
Sedation and analgesia
1.3
9.1
710
5616
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
2.3
9.1
79
345
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
3.1
9.0
47
152
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
9.0
214
1340
A98
ICPC
Health maint/preventive medicine
1.4
9.0
4205
40850
SPAT1301
SPAT
No procedures
1.3
9.0
1154
9726
E27.9
ICD-10 Finland
Disorder of adrenal gland, unspecified
15.6
9.0
14
9
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
9.0
9.0
18
20
D02
ICPC
Abdominal pain epigastric
1.7
9.0
197
1206
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
9.0
168
983
M01AG02
ATC
tolfenamic acid; oral, rectal
1.4
9.0
539
4093
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.7
9.0
187
1132
B01AB10
ATC
tinzaparin; parenteral
1.6
8.9
243
1579
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
8.9
235
1514
RD211
NOMESCO Finland
NA
1.7
8.9
164
958
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
8.9
889
7267
D44.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Parathyroid gland
24.0
8.9
12
5
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.3
8.9
42
127
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
8.9
177
1055
-1
NOMESCO Finland
NA
1.2
8.9
1173
9922
A10BJ02
ATC
liraglutide; parenteral
2.1
8.8
95
456
207
Kela drug reimbursment
Chronic arrhythmias
1.4
8.8
467
3472
K86.2
ICD-10 Finland
Cyst of pancreas
3.4
8.7
40
118
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
8.7
677
5348
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
8.7
263
1749
J01FA06
ATC
roxithromycin; oral
1.2
8.7
1507
13118
XX9XW
NOMESCO Finland
NA
3.5
8.7
38
108
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
4.7
8.7
28
60
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.8
8.7
145
818
AA4AD
NOMESCO Finland
CT of sella turcica
50.1
8.7
10
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.5
8.6
274
1843
XX3DW
NOMESCO Finland
Time consuming IT work
1.4
8.6
361
2575
H02AB07
ATC
prednisone; oral
1.4
8.6
491
3700
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.3
8.6
73
316
G93.0
ICD-10 Finland
Cerebral cysts
5.2
8.6
25
48
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
8.5
1499
13063
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.1
8.5
93
450
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
8.5
121
648
C09DA01
ATC
losartan and diuretics; oral
1.4
8.5
372
2675
C08CA10
ATC
nilvadipine; oral
2.3
8.5
77
341
N03AX09
ATC
lamotrigine; oral
1.8
8.5
151
874
N02AA05
ATC
oxycodone; systemic
1.4
8.5
476
3578
J01CA04
ATC
amoxicillin; systemic
1.2
8.5
3244
30512
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
6.4
8.5
21
33
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
8.4
1022
8549
BC5AQ
NOMESCO Finland
Chromaffine tissue SPECT with low dose CT
90.2
8.4
9
*
M79.1
ICD-10 Finland
Myalgia
1.4
8.4
428
3165
WX704
NOMESCO Finland
Intubation
1.5
8.4
246
1625
Z72.0
ICD-10 Finland
Tobacco use
2.0
8.3
96
475
JAH01
NOMESCO Finland
Laparoscopy
1.7
8.3
153
892
2550C
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERSECRETIO HYPOFYSEOS]
+∞
8.3
8
*
M14.5*E22.0
ICD-10 Finland
Arthropathy associated with acromegaly
+∞
8.3
8
*
2535A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Diabetes insipidus
+∞
8.3
8
*
2549
FHL
NA
+∞
8.3
8
*
E2300, D352
ICD-10 Finland
NA
+∞
8.3
8
*
D352, E220
ICD-10 Finland
NA
+∞
8.3
8
*
8680/3-C75.5
ICD-O-3
Paraganglioma, NOS, of aortic body and other paraganglia
+∞
8.3
8
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
8.3
222
1435
104
Kela drug reimbursment
Thyroid insufficiency
1.5
8.3
257
1723
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
8.3
153
896
C09CA06
ATC
candesartan; oral
1.3
8.3
770
6230
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
2.4
8.3
68
290
XJH00
NOMESCO Finland
Transanal ultrasonography
1.6
8.3
193
1205
A10BJ06
ATC
semaglutide; parenteral
1.9
8.2
113
600
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
8.2
224
1455
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.9
8.2
110
578
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
8.1
471
3554
L17
ICPC
Foot/toe symptom/complaint
1.3
8.1
901
7451
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.3
8.1
73
325
C08CA05
ATC
nifedipine; systemic
1.6
8.1
211
1357
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
3.6
8.1
35
99
R03BA05
ATC
fluticasone; inhalant
1.3
8.1
626
4942
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
4.3
8.1
28
65
R51
ICD-10 Finland
Headache
1.7
8.1
175
1072
K07
ICPC
Swollen ankles/oedema
1.8
8.0
143
826
JN4AD
NOMESCO Finland
Body CT examination
1.5
8.0
261
1766
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.1
8.0
84
399
E27.8
ICD-10 Finland
Other specified disorders of adrenal gland
22.0
8.0
11
5
K92.1
ICD-10 Finland
Melaena
1.7
8.0
155
918
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
8.0
217
1409
N06AX12
ATC
bupropion; oral
1.6
8.0
182
1132
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.6
8.0
182
1133
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
8.0
2685
24850
H53.2
ICD-10 Finland
Diplopia
1.9
7.9
106
557
A10BH05
ATC
linagliptin; oral
1.7
7.9
158
945
J02AC01
ATC
fluconazole; systemic
1.2
7.9
1466
12821
C09DA03
ATC
valsartan and diuretics; oral
1.7
7.8
164
995
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.8
7.8
123
685
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.8
7.8
31
82
C07BB07
ATC
bisoprolol and thiazides; systemic
1.7
7.8
143
836
R01AD12
ATC
fluticasone furoate; nasal
1.2
7.8
1022
8618
H01
ICPC
Ear pain/earache
1.4
7.8
340
2442
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.6
7.8
210
1363
E26
ICD-10 Finland
Hyperaldosteronism
45.0
7.7
9
*
X57
ICD-10 Finland
Unspecified privation
2.2
7.7
77
359
AN1
HP
Coronary angiography
1.4
7.7
382
2812
A08
ICPC
Swelling
1.7
7.7
140
815
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
7.7
972
8159
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.8
7.6
131
751
R01AD09
ATC
mometasone; nasal
1.2
7.6
1671
14836
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
2.8
7.6
46
166
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
7.6
1490
13090
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
8.0
7.6
16
20
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.2
7.6
37
116
BBA50
NOMESCO Finland
Total parathyroidectomy
11.8
7.6
13
11
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
7.5
1510
13293
JEA01
NOMESCO Finland
Laparoscopic appendectomy
1.8
7.5
113
621
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.7
7.5
159
967
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.8
7.5
122
686
R55
ICD-10 Finland
Syncope and collapse
1.4
7.5
348
2532
R06AE07
ATC
cetirizine; oral
1.2
7.5
1601
14178
U04
ICPC
Incontinence urine
1.7
7.5
147
879
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
7.4
301
2133
A55
ICPC
General and Unspecified, Local injection/infiltration
2.9
7.4
41
140
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
7.4
284
1992
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.1
7.4
76
361
AA4BD
NOMESCO Finland
Extensive CT of sella turcica
80.2
7.4
8
*
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
80.2
7.4
8
*
M01AB55
ATC
diclofenac, combinations; oral
1.5
7.4
236
1590
A10BK03
ATC
empagliflozin; oral
1.5
7.4
239
1616
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
7.4
355
2596
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
7.4
363
2665
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
7.4
738
6021
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.8
7.4
121
682
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
7.4
1977
17865
ZXA05
NOMESCO Finland
Left side
1.2
7.4
903
7548
C09BA02
ATC
enalapril and diuretics; systemic
1.5
7.4
283
1985
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
7.3
657
5285
160
Kela drug reimbursment
exenatide
2.1
7.3
79
380
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
7.3
452
3448
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
7.3
945
7943
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.3
905
7571
N03AX11
ATC
topiramate; oral
2.0
7.3
88
443
N05BA01
ATC
diazepam; systemic, rectal
1.3
7.3
439
3336
R52.9
ICD-10 Finland
Pain, unspecified
1.4
7.3
284
1998
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.0
7.3
84
418
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
7.3
188
1209
E24.1
ICD-10 Finland
Nelson syndrome
+∞
7.3
7
*
H01AX01
ATC
pegvisomant; parenteral
+∞
7.3
7
*
9350/1-C75.1
ICD-O-3
Craniopharyngioma, NOS, of pituitary gland
+∞
7.3
7
*
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
10.9
7.3
13
12
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
10.9
7.3
13
12
XLA10
NOMESCO Finland
NA
1.6
7.3
160
987
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.7
7.2
131
765
Z31.5
ICD-10 Finland
Genetic counselling
1.6
7.2
158
971
E66
ICD-10 Finland
Obesity
1.7
7.2
141
841
SPAT1240
SPAT
Therapeutic discussion
1.4
7.2
331
2405
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.9
7.2
96
505
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.2
7.2
66
298
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
7.2
271
1896
M01AH05
ATC
etoricoxib; oral
1.2
7.2
2279
20889
8700/3-C74.1
ICD-O-3
Pheochromocytoma, NOS, of medulla of adrenal gland
30.0
7.1
9
*
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
2.9
7.1
41
142
N20.9
ICD-10 Finland
Urinary calculus, unspecified
2.0
7.1
91
471
U05
ICPC
Urination problems other
1.7
7.1
155
951
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
7.1
237
1616
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
2.6
7.1
50
197
J20
ICD-10 Finland
Acute bronchitis
1.4
7.1
317
2292
XG410
NOMESCO Finland
Flow-volume spirometry
1.7
7.1
143
861
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
6.0
7.1
18
30
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.8
7.1
118
671
S76
ICPC
Skin infection other
1.6
7.0
161
1002
G03DB01
ATC
dydrogesterone; oral
1.3
7.0
436
3331
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.1
7.0
77
376
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
7.0
313
2261
J01EA01
ATC
trimethoprim; systemic
1.2
7.0
869
7273
C02CA01
ATC
prazosin; oral
2.6
7.0
49
193
N06AB06
ATC
sertraline; oral
1.4
6.9
346
2551
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
3.1
6.9
35
113
B01AF02
ATC
apixaban; oral
1.4
6.9
304
2189
U14
ICPC
Kidney symptom/complaint
2.6
6.9
47
183
M02AA10
ATC
ketoprofen; topical
1.3
6.9
544
4300
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.5
6.9
245
1694
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
6.9
404
3057
R03BA02
ATC
budesonide; inhalant
1.3
6.9
597
4783
J01FA09
ATC
clarithromycin; systemic
1.2
6.9
1139
9823
M04AA01
ATC
allopurinol; systemic
1.4
6.9
396
2989
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
6.9
392
2952
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.1
6.8
71
339
A03
ICPC
Fever
1.3
6.8
495
3870
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
6.7
6.8
16
24
M01AH03
ATC
valdecoxib; oral
1.5
6.8
223
1518
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
5.0
6.8
20
40
N01
ICPC
Headache
1.4
6.8
304
2199
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
2.7
6.7
42
156
DCB00
NOMESCO Finland
Excision of lesion of middle ear
16.7
6.7
10
6
C10AC01
ATC
colestyramine; oral
1.9
6.7
92
489
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
3.2
6.7
33
105
L86
ICPC
Back syndrome with radiating pain
1.5
6.7
192
1265
D12
ICPC
Constipation
1.8
6.7
102
564
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.8
6.7
102
565
C07AG02
ATC
carvedilol; oral
1.5
6.7
193
1274
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
6.7
113
648
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
6.6
165
1050
R52.0
ICD-10 Finland
Acute pain
1.9
6.6
96
523
C07AB03
ATC
atenolol; systemic
1.5
6.6
188
1238
A05
ICPC
Feeling ill
1.6
6.6
166
1060
R52.2
ICD-10 Finland
Other chronic pain
1.8
6.6
108
610
J01FA15
ATC
telithromycin; oral
1.4
6.5
340
2523
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.5
6.5
48
196
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
6.5
241
1679
A12AA04
ATC
calcium carbonate; oral
2.3
6.5
56
247
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
6.5
487
3827
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.6
6.5
168
1082
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
6.5
2153
19736
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.5
6.5
194
1295
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.2
6.5
59
268
M54.3
ICD-10 Finland
Sciatica
1.5
6.4
192
1277
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.6
6.4
163
1046
E26.8
ICD-10 Finland
Other hyperaldosteronism
69.9
6.4
7
*
E22
ICD-10 Finland
Hyperfunction of pituitary gland
69.9
6.4
7
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.4
227
1568
R06.5
ICD-10 Finland
Mouth breathing
1.4
6.4
283
2042
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.8
6.4
101
563
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.5
6.4
196
1313
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
14.3
6.4
10
7
T92
ICPC
Gout
2.2
6.4
63
295
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
6.4
692
5695
SPAT1097
SPAT
Recording of ECG
1.3
6.4
516
4093
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.3
6.4
56
250
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.8
6.4
103
581
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
2.9
6.4
37
130
M02AA07
ATC
piroxicam; topical
1.2
6.4
1329
11702
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
2.6
6.4
42
161
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
6.3
168
1086
J01MA06
ATC
norfloxacin; oral
1.3
6.3
466
3649
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.8
6.3
93
509
D25.2
ICD-10 Finland
Subserosal leiomyoma of uterus
2.1
6.3
65
310
C09AA05
ATC
ramipril; oral
1.2
6.3
818
6869
R04.2
ICD-10 Finland
Haemoptysis
1.8
6.3
106
609
E260, D350
ICD-10 Finland
NA
+∞
6.2
6
*
D350, E260
ICD-10 Finland
NA
+∞
6.2
6
*
E220, D352
ICD-10 Finland
NA
+∞
6.2
6
*
2550X
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING NUD]
+∞
6.2
6
*
D44.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Craniopharyngeal duct
+∞
6.2
6
*
E22.88
ICD-10 Finland
Other hyperfunction of pituitary gland
+∞
6.2
6
*
R01AD08
ATC
fluticasone; nasal
1.2
6.2
1016
8738
M43.1
ICD-10 Finland
Spondylolisthesis
1.7
6.2
123
738
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
26.7
6.2
8
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
26.7
6.2
8
*
H35.20
ICD-10 Finland
Proliferative vitreoretinopathy
26.7
6.2
8
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
2.6
6.2
42
164
G04CA02
ATC
tamsulosin; oral
1.3
6.2
680
5607
162
Kela drug reimbursment
liraglutide
2.4
6.2
48
201
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.2
6.2
745
6207
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
6.2
727
6041
C09DA06
ATC
candesartan and diuretics; oral
1.4
6.2
245
1732
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.4
6.1
47
194
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.6
6.1
145
913
E22.2
ICD-10 Finland
Syndrome of inappropriate secretion of antidiuretic hormone
7.7
6.1
13
17
M10.9
ICD-10 Finland
Gout, unspecified
1.5
6.1
191
1286
P06
ICPC
Sleep disturbance
1.4
6.1
295
2167
H93.1
ICD-10 Finland
Tinnitus
1.5
6.1
220
1526
C08DB01
ATC
diltiazem; oral
1.6
6.1
156
1004
N64.3
ICD-10 Finland
Galactorrhoea not associated with childbirth
4.6
6.1
19
41
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
6.1
185
1239
BB1BN
NOMESCO Finland
Parathyroid gland isotope imaging, 2 isotopes
12.5
6.1
10
8
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
6.1
251
1792
ZX114
NOMESCO Finland
Intramuscular
2.3
6.1
51
224
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
6.1
301
2220
WZA90
NOMESCO Finland
Other doctors statement
1.2
6.1
787
6610
K04.0
ICD-10 Finland
Pulpitis
1.4
6.0
286
2090
R95
ICPC
Chron obstructive pulmonary disease
1.9
6.0
85
460
SPAT1312
SPAT
General health counselling
1.2
6.0
1123
9780
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
4.4
6.0
20
46
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.4
6.0
47
198
J01DC02
ATC
cefuroxime; systemic
1.5
6.0
186
1252
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
6.0
303
2237
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
6.0
261
1879
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(37021550) Renin [Units/volume] in Plasma --upright
209
67
32.48
323.31
1.3
1.2
mu/l
62.5
56.9
0.10
156
48
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
1038
456
28.32
307.65
1.5
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
1242
1177
13.63
307.65
4.4
1.4
mu/l
377.4
297.6
2.70
1208
1067
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
228
73
32.65
307.65
1.3
1.0
pmol/l
272.9
261.9
0.12
166
49
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
1128
500
28.68
307.65
1.5
1.3
nmol/l
0.6
0.6
0.84
1102
475
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
452
100
49.50
307.65
3.8
1.5
ug/l
1.0
1.3
0.63
437
92
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
1039
236
55.03
307.65
3.1
1.6
nmol/l
17.1
19.2
2.64
1024
220
(43055514) Macroprolactin [Presence] in Serum or Plasma
241
67
37.70
307.65
1.9
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
1011
437
28.61
307.65
1.5
1.3
nmol/l
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
285
152
19.80
307.65
1.2
1.4
umol/l
2.6
4.6
8.79
263
142
(3036481) Cortisol [Moles/volume] in Serum or Plasma
2561
3791
12.56
307.65
4.0
2.1
nmol/l
302.7
376.3
35.90
2425
3484
(3011985) Renin [Units/volume] in Plasma
988
474
25.61
307.65
1.5
1.4
mu/l
59.2
50.6
0.42
927
416
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
928
446
25.21
307.65
1.4
1.3
pmol/l
256.1
296.9
1.81
806
338
(3035637) Corticotropin [Mass/volume] in Plasma
729
478
17.63
307.65
2.1
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
1132
509
28.30
307.65
1.5
1.3
nmol/l
0.2
0.3
1.07
88
28
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
213
53
41.90
307.65
2.3
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
523
157
37.00
307.65
2.0
1.5
nmol/l
4.2
2.9
0.56
452
125
(3009214) Lutropin [Units/volume] in Serum or Plasma
680
989
7.78
307.65
1.9
1.3
u/l
7.8
11.2
6.49
565
808
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
397
398
10.73
307.65
3.8
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
971
2913
3.88
278.71
4.3
2.1
nmol/l
11.7
12.7
3.27
900
2569
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3309
21591
2.52
208.73
9.0
6.8
mmol/l
1.2
1.2
0.89
2872
18226
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2979
19619
2.25
167.82
7.4
6.0
mmol/l
1.2
1.2
0.43
2800
17763
(3013826) Glucose [Moles/volume] in Serum or Plasma
3543
25354
2.30
158.69
6.0
4.7
mmol/l
6.8
6.7
0.73
3401
23739
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
285
504
5.93
154.44
3.6
3.2
nmol/l
5.0
16.8
0.55
277
489
(3033923) Metanephrine [Moles/time] in 24 hour Urine
130
82
16.24
152.68
1.2
1.1
umol/24h
0.8
0.7
0.28
57
43
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
204
275
7.69
143.06
1.4
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
558
1770
3.42
142.36
1.8
1.3
iu/l
22.5
30.9
7.21
460
1526
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4196
33239
2.48
133.92
5.9
4.0
pmol/l
14.8
14.8
0.78
3974
30256
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
700
2650
2.90
131.60
3.2
3.2
pmol/l
4.4
4.4
1.56
641
2348
(3024561) Albumin [Mass/volume] in Serum or Plasma
2721
18643
1.99
121.80
5.6
4.9
g/l
35.2
35.5
1.89
2581
17325
(3018418) pH of Serum or Plasma
2063
12902
2.01
119.48
4.8
4.1
ph
7.4
7.4
0.66
418
2471
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
315
774
4.27
115.73
2.8
1.9
pmol/l
176.1
201.2
3.26
299
733
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3112
22556
1.97
115.69
6.3
6.3
umol/l
10.6
11.3
2.77
2979
21417
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
381
1086
3.71
113.78
2.6
1.7
nmol/l
41.7
41.8
0.01
374
1043
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4135
33435
2.25
110.92
8.8
7.7
u/l
79.3
78.0
0.82
3979
31471
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
253
545
4.83
109.61
1.9
1.4
nmol/l
0.3
0.4
0.25
182
419
(3032080) INR in Blood by Coagulation assay
2526
17447
1.89
104.35
9.1
9.1
inr
1.2
1.2
0.86
787
5014
(3008295) Osmolality of Serum or Plasma
220
444
5.13
102.84
2.0
1.4
mosm/kgh2o
283.2
278.1
2.29
198
342
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
993
4948
2.25
102.67
6.9
7.4
kpa
5.2
5.1
3.50
959
4708
(3027801) Oxygen [Partial pressure] in Arterial blood
991
4948
2.24
101.89
6.9
7.3
kpa
13.2
12.4
4.13
953
4710
(3003396) Base excess in Arterial blood by calculation
986
4928
2.24
101.05
6.9
7.4
mmol/l
1.1
1.1
0.02
773
3824
(3014576) Chloride [Moles/volume] in Serum or Plasma
1035
5323
2.18
98.55
6.3
7.0
mmol/l
104.6
104.4
0.44
1014
5209
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1057
5612
2.11
92.05
6.2
6.1
mmol/l
1.0
1.0
1.69
995
5228
(4035726)
812
3947
2.26
87.99
1.3
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
709
3280
2.35
86.22
4.8
3.8
ng/l
97.8
90.6
1.00
630
2822
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
548
2254
2.60
86.00
6.8
9.6
mmol/l
24.2
24.3
0.35
527
2114
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2498
17884
1.78
85.52
2.9
2.3
nmol/l
76.1
78.0
3.06
2307
16065
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4561
39570
2.44
85.38
6.3
4.8
mu/l
1.7
2.1
4.95
4264
36256
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2756
20312
1.78
85.25
4.6
4.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
3235
25001
1.80
84.89
8.9
9.2
e9/l
4.4
4.1
10.49
2854
21829
(3026782) Osmolality of Urine
1385
8351
1.90
82.83
3.0
2.8
mosm/kgh2o
536.8
542.9
0.45
1217
7110
(3044640) Blood type and Crossmatch panel - Blood
2022
13747
1.78
81.50
2.7
2.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1700
11028
1.81
79.94
4.1
4.0
%
93.1
90.6
3.58
1650
10752
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1982
13599
1.75
75.91
2.9
2.6
u/l
59.2
57.9
0.29
1855
12552
(3006504) Eosinophils/100 leukocytes in Blood
2685
20168
1.70
72.83
6.4
6.1
%
2.7
2.9
2.23
2539
18774
(3013707) Erythrocyte sedimentation rate by Westergren method
3857
32066
1.83
72.33
4.8
4.1
mm/h
13.4
12.3
4.65
3640
29702
(3019550) Sodium [Moles/volume] in Serum or Plasma
4879
44345
3.31
72.29
24.5
16.3
mmol/l
139.7
139.7
0.58
4845
43272
(3022096) Basophils/100 leukocytes in Blood
2618
19584
1.69
71.66
6.4
6.2
%
0.7
0.7
1.32
2469
18250
(3019069) Monocytes/100 leukocytes in Blood
2691
20279
1.69
71.62
6.7
6.4
%
8.4
8.6
2.55
2545
18984
(3023368) Bacteria identified in Blood by Culture
1721
11493
1.75
71.48
4.5
4.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
4882
44472
3.29
70.35
24.7
16.4
mmol/l
3.9
4.0
8.15
4840
43317
(3006315) Basophils [#/volume] in Blood
2823
21623
1.68
69.96
6.0
5.9
e9/l
0.0
0.0
1.70
2450
18650
(3013115) Eosinophils [#/volume] in Blood
2896
22356
1.68
69.44
6.2
6.1
e9/l
0.2
0.2
0.04
2557
19611
(3001604) Monocytes [#/volume] in Blood
2803
21529
1.67
67.84
5.9
5.9
e9/l
0.6
0.6
4.06
2426
18573
(3002030) Lymphocytes/100 leukocytes in Blood
2722
20785
1.66
67.07
6.5
6.2
%
27.2
27.9
2.70
2571
19340
(3002582) Erythrocytes [#/volume] in Urine
1873
12988
1.70
66.75
3.7
3.2
e6/l
140.6
86.6
0.40
1482
9956
(3019198) Lymphocytes [#/volume] in Blood
2858
22115
1.66
66.73
6.0
6.0
e9/l
1.9
1.9
0.32
2530
19444
(3016502) Oxygen saturation in Arterial blood
819
4417
2.02
66.26
7.6
7.8
%
95.9
95.8
0.21
795
4239
(3018010) Neutrophils/100 leukocytes in Blood
2679
20511
1.64
64.15
6.3
6.0
%
58.3
57.2
4.35
2539
19165
(3031040) Bacteria [#/volume] in Urine by Automated count
3461
28307
1.69
63.83
5.4
4.4
e6/l
1258.3
1624.9
0.20
49
378
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
65
57
11.54
62.89
3.3
2.3
pmol/l
101.4
78.2
0.24
52
52
(3018095) Leukocytes [#/volume] in Urine
2100
15178
1.65
62.77
4.3
3.7
e6/l
124.4
100.3
0.37
1557
10723
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
58
43
13.63
62.17
1.2
1.1
umol/24h
2.1
1.6
1.92
58
43
(3036603) Volume of Urine
133
270
5.03
61.67
1.5
1.6
ml
1721.1
1893.9
0.30
14
58
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1862
13131
1.66
60.75
2.3
2.2
u/l
185.2
221.5
0.99
1768
12312
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4738
42989
2.44
59.94
19.7
14.3
mg/l
23.3
23.5
0.16
4129
34045
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1553
10488
1.69
59.56
2.7
2.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
752
4089
1.98
58.92
8.0
8.1
g/l
123.8
121.5
2.31
724
3930
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1145
7132
1.78
58.55
3.4
3.4
mmol/l
0.8
0.8
0.33
1081
6651
(3030467) Casts [#/volume] in Urine by Automated count
1719
11968
1.66
58.41
3.5
3.1
e6/l
0.4
0.4
0.04
1326
8999
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
967
5764
1.84
57.08
2.8
2.6
%
21.0
22.9
3.96
842
4929
(3021589) Normoblasts [#/volume] in Blood
2495
19105
1.60
57.05
11.1
9.7
e9/l
0.0
0.0
0.46
2083
15586
(42870588) Differential panel, method unspecified - Blood
2019
14736
1.61
56.16
6.1
6.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1017
6191
1.80
55.88
2.7
2.5
g/l
2.4
2.3
0.99
949
5744
(3000991) Gas panel - Venous blood
661
3495
2.02
55.86
8.1
8.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4538
40712
2.04
55.24
19.0
13.3
ml/min/173m2
80.8
80.7
0.22
4052
33637
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1561
10738
1.65
54.85
2.6
2.2
mg/l
3.0
3.0
0.82
1385
9170
(3037467) Urinalysis macro (dipstick) panel - Urine
3532
29552
1.63
54.42
5.1
4.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1073
6706
1.76
53.63
2.8
2.5
umol/l
12.3
13.1
3.54
1012
6234
(36304419) Bacteria [Presence] in Urine
1641
11620
1.61
50.36
3.5
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1784
12889
1.59
50.29
3.5
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2331
17928
1.55
49.77
2.3
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2367
18268
1.55
49.75
3.4
2.8
ug/l
130.8
128.5
0.15
2201
16900
(3000850) Epithelial cells [#/volume] in Urine
1342
9071
1.65
49.58
3.0
2.6
e6/l
6.0
5.6
0.47
1188
7939
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1043
6682
1.71
46.92
2.0
2.1
s
29.6
29.8
0.30
1010
6479
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1898
14131
1.55
45.75
3.1
3.3
u/l
35.1
35.4
0.03
1811
13410
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2278
17674
1.52
45.19
2.2
2.0
pmol/l
94.1
95.9
0.89
1241
9055
(3020564) Creatinine [Moles/volume] in Serum or Plasma
4888
45714
2.67
44.99
24.5
16.7
umol/l
79.8
76.9
4.73
4888
45700
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4400
39726
1.78
43.25
7.2
5.8
mmol/mol
40.6
39.7
8.15
4166
36745
(3010370) Gastrin [Moles/volume] in Serum or Plasma
53
61
8.77
42.24
3.1
1.9
pmol/l
47.2
35.6
0.39
47
52
(3003181) Sodium [Moles/volume] in Urine
208
748
2.86
41.90
1.6
1.3
mmol/l
73.1
62.3
2.38
183
603
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
502
2678
1.97
40.75
7.8
9.3
%
0.7
0.7
0.04
502
2658
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2099
16250
1.50
40.65
4.0
3.6
ng/l
67.2
75.6
0.08
1495
11061
(3014007) Fractional oxyhemoglobin in Arterial blood
503
2694
1.96
40.35
7.8
9.3
%
94.1
94.1
0.04
503
2685
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
502
2687
1.96
40.34
7.8
9.1
%
1.4
1.3
0.37
502
2671
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1220
8413
1.59
40.14
4.1
3.7
ng/l
300.2
491.8
0.55
929
6522
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1650
12182
1.52
39.98
3.2
3.0
ng/l
1781.4
1338.3
1.61
1443
10446
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
452
2356
2.01
39.15
9.0
10.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3325
28342
1.50
39.06
3.7
3.1
u/l
54.2
48.8
2.32
3143
26345
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1015
6799
1.62
37.35
3.1
2.9
e6/l
2.9
2.5
0.47
571
3665
(3021447) Carbon dioxide [Partial pressure] in Venous blood
646
3853
1.77
36.72
5.0
3.8
kpa
5.8
5.8
0.09
625
3744
(3015377) Calcium [Moles/volume] in Serum or Plasma
1906
14710
1.47
36.25
3.5
3.4
mmol/l
2.4
2.4
3.17
1679
12827
(3020779) Urea [Moles/volume] in Serum or Plasma
646
3869
1.77
36.17
7.9
7.7
mmol/l
9.8
9.7
0.02
615
3700
(3009508) Creatinine [Moles/volume] in Urine
1781
13590
1.48
35.76
3.5
3.2
mmol/l
7.4
7.5
0.15
1540
11437
(3014111) Lactate [Moles/volume] in Serum or Plasma
629
3753
1.77
35.65
6.9
7.1
mmol/l
1.2
1.3
2.44
604
3623
(3002032) Base excess in Venous blood by calculation
640
3845
1.76
35.40
5.1
3.9
mmol/l
2.0
2.0
0.05
523
3145
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1024
6959
1.59
35.22
2.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
3496
30494
1.47
33.44
4.2
3.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
774
4983
1.65
33.01
2.6
2.9
umol/l
6.7
8.0
0.97
657
4359
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4529
41855
1.73
32.98
5.3
4.6
mmol/l
6.0
5.9
5.13
4225
38194
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
473
2650
1.87
32.87
4.3
3.6
kpa
5.2
5.2
1.37
437
2461
(3019060) Gas panel - Arterial blood
498
2857
1.82
32.04
6.0
4.9
—
—
—
0
0
(3009343) pH of Capillary blood
465
2615
1.86
31.90
4.2
3.6
ph
7.4
7.4
0.18
54
335
(3020682) Albumin/Creatinine [Ratio] in Urine
1745
13484
1.45
31.88
4.3
4.0
mg/mmol
12.1
9.0
1.24
1176
8470
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
159
576
2.82
31.62
2.0
1.4
u/l
19.7
29.6
3.87
145
470
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
659
4112
1.69
31.58
2.3
2.3
g/l
0.2
0.2
1.47
620
3845
(3042936) Bacteria identified in Isolate by Culture
895
6044
1.58
31.21
2.2
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
591
3597
1.73
31.01
4.0
4.0
mmol/l
1.2
1.2
0.02
547
3144
(3002256) Pathology report gross observation
854
5721
1.59
30.78
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1666
12826
1.44
30.78
3.6
3.3
mg/l
539.8
350.7
0.75
1131
8019
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1311
9645
1.48
30.65
1.8
1.7
mg/l
1.1
1.2
1.36
1013
7365
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
447
2522
1.85
30.30
4.1
3.6
mmol/l
2.1
1.8
0.76
341
1883
(3021960) Folate [Moles/volume] in Serum or Plasma
1347
9985
1.47
30.24
1.6
1.5
nmol/l
20.5
20.7
0.14
1187
8524
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
340
1772
1.98
29.28
6.7
5.3
%
1.8
1.6
1.29
321
1642
(3044290) Cell count panel - Cerebral spinal fluid
205
875
2.40
29.20
1.4
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
580
3568
1.71
29.18
2.4
2.6
g/l
66.0
66.4
0.65
527
3267
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1039
7355
1.52
29.08
2.9
2.7
e6/l
1.1
1.2
0.12
597
4187
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
215
941
2.34
28.93
1.4
1.4
e6/l
106.2
24.0
0.65
156
719
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
215
942
2.34
28.86
1.4
1.4
e6/l
2065.0
1156.7
0.57
168
761
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
741
4879
1.61
28.54
3.8
4.4
u/l
230.3
244.7
2.33
691
4624
(3027945) Reticulocytes/100 erythrocytes in Blood
728
4774
1.61
28.51
2.9
2.5
%
1.8
1.8
0.71
648
4231
(40768797) Stomach Pathology biopsy report
893
6143
1.55
28.45
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3939
35554
1.47
28.40
23.9
17.4
%
13.9
13.7
8.77
3900
34790
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
646
4128
1.65
28.06
2.6
2.4
u/l
31.7
50.0
0.92
574
3512
(3009261) Glucose [Presence] in Urine by Test strip
2536
21256
1.38
27.77
3.9
3.7
estimate
0.0
0.0
0.36
569
3835
(3007930) Methemoglobin/Hemoglobin.total in Blood
332
1762
1.95
27.10
6.7
5.3
%
0.9
0.9
1.42
313
1637
(40761511) CBC panel - Blood by Automated count
4738
44740
1.83
26.94
19.2
13.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2502
21015
1.37
26.57
5.3
4.9
estimate
0.0
0.0
0.80
592
3939
(3037522) Nuclear Ab [Titer] in Serum
848
5867
1.53
26.11
1.4
1.3
titre
567.8
530.8
0.19
170
1222
(3046904) Somatotropin [Units/volume] in Serum or Plasma
30
5
60.33
25.96
3.7
1.0
mu/l
1.8
2.6
—
30
5
(3026493) Urate [Moles/volume] in Serum or Plasma
1482
11453
1.41
25.78
2.8
2.7
umol/l
5065.7
4532.0
0.17
1294
9926
(3008152) Bicarbonate [Moles/volume] in Arterial blood
455
2713
1.74
25.50
8.6
6.9
mmol/l
25.2
24.6
3.67
425
2513
(3007164) IgA [Mass/volume] in Serum or Plasma
1111
8163
1.46
25.40
1.4
1.5
g/l
2.4
2.4
0.27
679
4943
(3004588) Protein electrophoresis panel - Serum or Plasma
486
2961
1.71
25.19
2.4
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
1434
11064
1.41
25.03
6.6
6.9
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
54
111
4.91
24.79
1.4
1.5
ug/l
0.5
0.4
0.57
33
71
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
38
57
6.71
24.20
1.4
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2477
20962
1.35
24.12
3.9
3.6
estimate
0.0
0.0
0.80
578
3871
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
185
824
2.29
23.94
3.0
3.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
302
1622
1.92
23.77
2.1
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
115
410
2.85
23.63
1.6
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
531
3372
1.64
23.44
3.8
3.9
%
0.8
0.6
0.60
112
749
(3021440) Promyelocytes/100 leukocytes in Blood
548
3508
1.63
23.43
4.0
4.2
%
0.1
0.2
0.76
147
958
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
222
1076
2.11
23.30
1.3
1.3
mg/l
522.7
524.3
0.02
209
1013
(3023520) Reticulocytes [#/volume] in Blood
556
3583
1.62
23.12
3.1
2.6
e9/l
73.0
70.3
1.04
425
2702
(3017181) Myelocytes/100 leukocytes in Blood
569
3688
1.61
23.11
3.9
4.1
%
1.0
0.9
0.29
154
1038
(3024354) Oxygen [Partial pressure] in Venous blood
501
3146
1.66
23.10
3.6
3.1
kpa
4.7
4.6
0.54
483
3049
(3028626) Oxygen [Partial pressure] in Capillary blood
198
921
2.20
23.08
3.7
3.0
kpa
8.1
8.1
0.08
181
852
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
319
1765
1.86
22.91
2.3
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
501
3154
1.65
22.87
1.6
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
115
419
2.78
22.71
1.6
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
792
5552
1.50
22.64
22.8
24.3
inr
1.3
1.3
0.06
152
801
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4804
45841
1.83
22.31
13.1
10.6
u/l
27.6
26.2
2.42
4704
44216
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
303
1667
1.87
22.15
2.4
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
303
1668
1.87
22.11
2.4
2.3
g/l
7.4
7.4
0.04
216
1269
(3015235) Bicarbonate [Moles/volume] in Capillary blood
217
1064
2.09
22.10
4.2
3.1
mmol/l
25.5
25.0
0.99
181
929
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
302
1667
1.86
21.85
2.4
2.3
g/l
3.7
3.8
0.60
214
1217
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
59
145
4.10
21.73
1.6
1.5
pmol/l
14.8
15.4
0.27
53
123
(3047181) Lactate [Moles/volume] in Blood
261
1379
1.94
21.57
8.2
6.3
mmol/l
1.3
1.3
0.39
234
1199
(3016038) Potassium [Moles/volume] in Urine
87
279
3.16
21.56
1.3
1.2
mmol/l
33.2
35.7
0.45
81
236
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
285
1553
1.88
21.46
2.3
2.4
g/l
9.8
10.3
0.94
235
1328
(3013512) EKG study
1571
12570
1.36
21.26
4.3
3.9
—
—
—
0
0
(3019225) pH of Specimen
645
4383
1.54
21.25
6.9
4.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
119
457
2.64
21.25
1.5
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1057
7927
1.42
21.10
1.8
1.7
nmol/l
1087.7
1174.0
2.46
838
5984
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
27
32
8.48
21.00
2.9
2.6
pmol/l
272.3
114.5
—
8
13
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1210
9299
1.39
20.95
1.3
1.3
u/ml
1.0
1.8
3.77
303
2440
(3005719) IgG [Mass/volume] in Serum or Plasma
508
3280
1.61
20.88
2.6
2.7
g/l
10.2
10.5
0.73
462
2985
(3027273) Bicarbonate [Moles/volume] in Venous blood
339
1967
1.77
20.81
5.1
3.3
mmol/l
25.2
25.3
0.28
324
1904
(3007461) Platelets [#/volume] in Blood
4938
47657
2.14
20.57
30.2
21.1
e9/l
256.1
251.3
5.41
4870
46471
(3022313) Gas panel - Capillary blood
328
1895
1.78
20.43
4.3
3.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
4938
47677
2.12
20.22
30.0
21.0
pg
30.2
30.3
9.41
4913
47015
(3024731) MCV [Entitic volume]
4938
47679
2.12
20.18
30.0
21.0
fl
90.9
91.1
2.22
4913
47020
(3000963) Hemoglobin [Mass/volume] in Blood
4939
47696
2.13
20.12
30.4
21.2
g/l
134.3
135.2
4.20
4911
47041
(3026361) Erythrocytes [#/volume] in Blood
4938
47685
2.12
20.08
30.1
21.1
e12/l
4.5
4.5
0.23
4860
46358
(3041096) Erythrocytes [Presence] in Urine by Automated
1415
11224
1.36
19.99
3.8
3.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
507
3306
1.59
19.97
4.0
4.2
%
0.1
0.3
0.41
120
811
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
662
4583
1.51
19.92
3.6
4.0
ug/l
31.6
22.9
0.26
542
3686
(3010813) Leukocytes [#/volume] in Blood
4938
47694
2.11
19.92
30.2
21.1
e9/l
7.1
6.7
16.16
4860
46348
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
330
1933
1.76
19.60
1.6
1.7
g/l
1.7
1.5
1.14
285
1665
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
544
3627
1.56
19.44
3.1
2.9
ng/l
204.0
184.8
0.48
505
3302
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4589
43478
1.55
19.34
5.5
4.9
mmol/l
2.7
2.8
7.31
4270
40063
(3021901) Oxygen saturation in Capillary blood
164
761
2.19
19.28
3.5
2.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
280
1570
1.83
19.26
2.4
2.4
g/l
3.0
3.1
0.46
215
1244
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
193
955
2.06
19.21
1.2
1.3
mmol/l
3.6
3.8
1.37
176
892
(3022145) Colonoscopy Study observation
701
4958
1.48
18.93
1.4
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
649
4521
1.50
18.90
3.3
3.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
393
2441
1.66
18.82
1.5
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1214
9485
1.37
18.66
4.2
4.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2977
26474
1.30
17.85
3.1
2.9
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
27
39
6.95
17.80
1.3
1.2
nmol/l
3.8
5.0
0.81
27
39
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1034
7932
1.38
17.68
3.1
3.0
mmol/l
2.5
2.5
2.68
910
6945
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4505
42687
1.47
17.14
4.9
4.5
mmol/l
4.6
4.7
13.05
4219
39562
(3015736) pH of Urine
1929
16265
1.30
17.14
3.5
3.4
—
5.6
—
0
13
(3004119) Hemoglobin [Mass/volume] in Venous blood
400
2556
1.61
17.08
3.7
3.2
g/l
127.6
129.0
0.59
380
2485
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
330
2013
1.68
16.92
4.8
4.2
mmol/l
24.1
24.2
0.15
312
1814
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
36
73
4.96
16.85
1.6
1.6
ng/l
167.1
123.5
0.54
36
73
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4346
40938
1.42
16.78
4.4
4.0
mmol/l
1.4
1.3
22.43
4024
37439
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4475
42395
1.45
16.58
4.9
4.4
mmol/l
1.4
1.5
36.81
4167
39064
(3007853) Bacteria identified in Skin by Aerobe culture
688
4990
1.44
16.14
1.9
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
305
1850
1.69
15.97
1.9
1.9
u/l
38.8
39.5
0.22
270
1640
(3009445) Proteinase 3 Ab [Units/volume] in Serum
297
1794
1.70
15.80
1.4
1.6
u/ml
5.7
16.8
—
6
43
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
66
218
3.05
15.66
1.8
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
236
1343
1.79
15.49
3.1
3.5
mg/l
50.5
97.2
0.56
187
1089
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
167
850
2.00
15.44
1.6
1.9
nmol/l
1.0
0.8
1.16
146
712
(1616796) Gas panel - Central venous blood
181
949
1.94
15.37
3.8
3.9
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
235
1341
1.79
15.29
3.1
3.5
mg/l
41.8
59.9
0.76
186
1088
(3012565) Volume of 24 hour Urine
66
223
2.99
15.07
1.8
2.4
ml
2086.6
1920.8
0.66
61
199
(3039000) Anion gap in Blood
187
1004
1.90
14.80
9.6
7.2
mmol/l
10.8
11.3
1.33
169
888
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
660
4823
1.42
14.78
1.8
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
187
1005
1.89
14.76
9.6
7.2
mmol/l
105.2
105.1
0.03
169
889
(3037756) Immunofixation for Serum or Plasma
169
880
1.95
14.66
1.6
1.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
227
1302
1.78
14.53
3.1
3.4
ratio
1.6
2.2
0.40
11
107
(3028026) IgM [Mass/volume] in Serum or Plasma
388
2558
1.56
14.48
1.6
1.9
g/l
1.2
1.4
1.48
349
2329
(3017143) Hepatitis C virus Ab [Presence] in Serum
632
4607
1.42
14.33
1.7
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
228
1315
1.77
14.32
2.2
2.2
g/l
37.4
37.7
0.37
187
1145
(3048689) Calprotectin [Mass/mass] in Stool
689
5105
1.40
14.23
2.1
2.3
ug/g
129.8
136.3
0.20
529
4007
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
222
1277
1.77
14.08
1.5
1.6
g/l
0.2
0.2
0.92
202
1204
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
656
4834
1.41
13.97
1.9
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
227
1318
1.76
13.94
1.5
1.4
ug/g
239.9
275.6
2.04
129
762
(3030981) Hyaline casts [#/volume] in Urine by Automated count
338
2180
1.59
13.87
3.4
2.8
e6/l
0.2
0.3
0.39
332
2126
(40760888) Immunoglobulin light chains.free panel - Serum
183
998
1.86
13.82
2.9
3.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
241
1438
1.71
13.44
2.4
2.4
g/l
0.4
1.0
3.23
203
1251
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
217
1262
1.75
13.26
2.3
2.3
g/l
0.0
0.0
2.13
195
1168
(46235355) HIV 1 and 2 tests - Meaningful Use set
868
6752
1.34
13.17
1.8
1.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
203
1164
1.77
13.03
2.3
2.3
g/l
0.0
0.0
0.00
181
1087
(3052851) Hemolysis interference index of Serum or Plasma
221
1307
1.72
12.74
3.3
3.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
223
1326
1.71
12.61
1.5
1.6
g/l
1.2
1.2
1.39
205
1250
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
237
1433
1.69
12.60
2.3
2.8
—
—
—
0
0
(3010421) pH of Blood
200
1154
1.76
12.58
3.6
4.3
ph
7.4
7.4
0.41
171
967
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
203
1177
1.75
12.56
2.3
2.3
g/l
0.0
0.0
0.00
181
1088
(3049717) Cytology report of Urine Cyto stain
257
1589
1.65
12.54
3.2
2.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
475
3371
1.45
12.40
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
375
2549
1.51
12.16
1.7
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
175
981
1.81
12.14
3.6
4.5
mmol/l
2.5
2.5
0.01
121
688
(3037121) Protein [Mass/volume] in Urine
239
1464
1.66
12.10
2.6
3.1
g/l
0.3
0.3
0.23
112
591
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
262
1643
1.63
12.10
4.5
3.9
mmol/l
25.0
24.9
0.36
246
1524
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
656
4957
1.37
11.93
1.7
1.7
%
1.5
1.5
0.40
570
4352
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
241
1486
1.65
11.90
2.4
2.3
ug/l
488.0
684.0
0.49
228
1396
(40761536) Microorganisms panel - Urine sediment
506
3662
1.42
11.87
4.5
4.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
163
901
1.84
11.85
3.8
3.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1394
11719
1.26
11.56
1.7
1.6
mmol/l
1.5
1.4
7.18
1194
9823
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1859
16152
1.24
11.46
4.2
3.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1389
11690
1.26
11.37
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
89
405
2.22
11.14
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
230
1427
1.64
11.10
1.5
1.6
titre
226.7
334.1
—
6
64
(4010399)
433
3083
1.44
11.10
1.5
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
191
1134
1.71
10.90
2.0
1.9
mg/l
10.9
11.2
0.22
173
1050
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
280
1830
1.56
10.89
4.6
3.9
%
48.9
48.9
0.02
273
1808
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1550
13260
1.24
10.88
5.4
4.9
ug/l
2.0
3.1
3.08
1411
11928
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
264
1707
1.58
10.76
2.3
2.0
ug/l
2.5
2.3
0.09
232
1521
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
163
935
1.77
10.52
1.4
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
204
1251
1.66
10.33
1.5
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
293
1960
1.53
10.27
3.2
2.7
%
1.4
1.2
2.29
288
1945
(3025549) Creatine [Moles/time] in 24 hour Urine
19
34
5.61
10.21
1.5
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
155
888
1.77
10.06
3.5
3.1
mmol/l
1.5
1.6
0.92
147
862
(3023183) Ammonium ion [Moles/volume] in Plasma
159
921
1.75
9.94
2.3
2.9
umol/l
32.1
34.9
0.77
138
788
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
723
5692
1.31
9.89
1.6
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
919
7470
1.28
9.86
1.3
1.3
iu/ml
32.2
32.7
0.04
279
2324
(3000492) Spirometry study
544
4110
1.36
9.84
1.5
1.5
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
14
19
7.39
9.69
1.0
1.0
pmol/l
85.2
78.0
—
6
10
(3024980) IgG subclass 4 [Mass/volume] in Serum
128
702
1.84
9.61
1.5
1.6
g/l
0.6
0.8
1.65
96
528
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
129
712
1.83
9.50
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
215
1367
1.60
9.44
1.7
1.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
283
1915
1.51
9.41
3.2
2.7
%
0.6
0.7
0.72
278
1836
(3004809) Band form neutrophils/100 leukocytes in Blood
127
701
1.83
9.36
3.9
3.3
%
1.3
1.5
0.24
91
539
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
224
1445
1.58
9.26
3.0
3.2
u/ml
0.4
0.3
1.06
139
830
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
30
85
3.54
9.20
3.1
2.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
332
2332
1.45
9.16
2.5
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
174
1065
1.66
8.93
1.9
1.8
iu/l
3.4
4.6
1.02
56
380
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
237
1565
1.54
8.85
3.3
3.4
u/ml
228.5
3396.9
1.07
199
1333
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
93
472
1.99
8.84
1.1
1.1
—
3.5
—
0
7
(3029937) Albumin [Presence] in Urine by Test strip
1324
11341
1.23
8.83
4.3
4.1
estimate
0.0
0.0
0.02
576
3817
(3025941) Bacteria identified in Stool by Culture
336
2383
1.44
8.81
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
105
558
1.90
8.73
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1097
9227
1.24
8.67
1.7
1.7
pmol/l
5844609.3
34166773.4
3.08
924
7683
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
89
450
2.00
8.56
1.0
1.1
—
63.8
—
0
7
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
867
7110
1.26
8.55
1.3
1.3
u/ml
8.0
12.6
1.39
315
2755
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
51
205
2.50
8.53
1.3
1.3
%
48.0
65.6
—
6
27
(3045716) Anion gap in Serum or Plasma
51
205
2.50
8.53
2.0
2.3
mmol/l
8.4
9.3
1.14
42
159
(3020891) Body temperature
252
1703
1.50
8.46
4.9
4.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
17
33
5.17
8.40
1.6
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
186
1177
1.60
8.37
1.2
1.2
titre
84.0
144.3
0.55
15
97
(40767503) Oxygen content in Capillary blood by calculation
152
922
1.67
8.11
2.7
2.6
%
16.8
16.1
1.61
85
465
(3006184) Hemoglobin [Mass/volume] in Capillary blood
155
947
1.66
8.05
2.3
2.3
g/l
131.6
128.1
0.93
103
676
(3017569) Oxygen content in Arterial blood
51
213
2.41
7.89
2.1
2.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
466
3566
1.34
7.74
3.2
2.7
ml/min/173m2
68.4
66.0
0.34
206
1424
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
146
888
1.66
7.73
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
146
888
1.66
7.73
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1234
10618
1.21
7.70
4.5
4.2
%
21.3
21.8
0.60
618
5158
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
70
340
2.07
7.56
1.2
1.3
mmol/l
2.1
2.1
0.00
64
317
(3042631) Mycobacterium sp identified in Specimen
106
593
1.80
7.56
2.5
2.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
918
7677
1.24
7.55
3.2
3.0
ug/l
0.8
0.7
0.24
657
5145
(3038515) Glucose [Moles/volume] in Venous blood
138
833
1.67
7.53
3.7
3.2
mmol/l
7.6
7.5
0.14
131
812
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
382
2850
1.37
7.49
1.2
1.2
iu/ml
135.8
150.1
0.26
122
1061
(3034770) Mitochondria Ab [Titer] in Serum
182
1181
1.56
7.40
1.2
1.2
titre
1561.4
935.8
—
7
36
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
181
1174
1.56
7.38
2.2
2.1
u/l
10814.5
4245.9
0.98
44
452
(3017354) Segmented neutrophils/100 leukocytes in Blood
83
433
1.93
7.36
4.0
3.4
%
61.4
58.4
0.39
42
276
(3015171) Extractable nuclear Ab [Units/volume] in Serum
248
1732
1.45
7.11
1.3
1.2
u/ml
0.2
1.4
2.98
19
157
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
57
262
2.19
7.11
1.4
1.1
u/l
79.0
83.4
0.17
50
230
(3000494) Fungus identified in Specimen by Culture
644
5214
1.27
7.00
1.6
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
49
213
2.31
6.98
1.9
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
187
1243
1.52
6.85
1.4
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
62
300
2.08
6.80
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
169
1104
1.55
6.71
1.3
1.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
10
14
7.15
6.69
1.2
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
84
455
1.86
6.69
1.3
1.2
u/l
49.6
58.4
1.39
67
310
(3043409) Potassium [Moles/volume] in Arterial blood
191
1285
1.51
6.63
4.4
4.1
mmol/l
3.8
3.9
1.95
178
1207
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
39
157
2.50
6.58
2.5
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
80
430
1.87
6.53
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
390
2982
1.33
6.53
1.4
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
84
459
1.84
6.52
4.7
4.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
393
3012
1.33
6.47
2.5
2.4
au/ml
17.3
23.8
—
6
163
(3023511) Choriogonadotropin [Units/volume] in Urine
101
585
1.74
6.46
1.4
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
50
227
2.21
6.46
1.4
1.4
nmol/l
1.4
1.2
0.72
44
176
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
470
3699
1.30
6.39
2.5
2.3
ug/l
6.1
7.7
0.95
415
3276
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
171
1138
1.52
6.26
3.1
3.4
mg/l
1.6
1.5
0.20
158
1051
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
53
250
2.13
6.24
1.3
1.2
u/l
21.8
19.5
0.15
44
214
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
361
2748
1.34
6.24
1.3
1.3
au/ml
28.4
52.3
—
5
123
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
66
340
1.95
6.14
1.2
1.2
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
16
39
4.11
6.08
1.4
1.3
mmol/l
148.4
162.2
0.19
16
34
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
312
2333
1.36
6.07
2.8
3.6
u/ml
125.5
57.4
0.32
300
2248
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
98
578
1.71
5.91
6.9
6.7
mg/l
11.8
11.8
0.01
88
540
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
63
324
1.96
5.90
1.1
1.1
mg/l
39.3
39.4
0.01
53
267
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
171
1156
1.50
5.84
1.1
1.1
u/ml
13.6
4.9
0.57
19
124
(3004451) EKG impression Narrative
46
212
2.18
5.77
1.2
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
185
1275
1.47
5.75
2.3
2.6
g/l
3.9
3.5
2.13
176
1205
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
115
718
1.62
5.60
1.2
1.3
u/l
26.6
40.4
1.03
104
624
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
55
276
2.00
5.54
5.7
6.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
178
1228
1.47
5.52
2.4
2.5
%
174.9
192.3
1.92
167
1170
(3009542) Hematocrit [Volume Fraction] of Blood
4046
38994
1.18
5.40
21.3
15.3
%
39.5
39.7
0.65
2868
27874
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
130
2.47
5.35
1.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
234
1713
1.38
5.24
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
220
1596
1.40
5.20
1.6
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
373
2930
1.29
5.18
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
175
1220
1.45
5.16
1.4
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
110
696
1.59
5.11
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
44
210
2.10
5.10
2.8
2.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
343
2671
1.30
5.09
1.3
1.3
u/ml
156.9
204.1
0.85
323
2466
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
48
237
2.04
5.09
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
60
321
1.88
5.06
1.2
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
124
815
1.53
4.90
1.3
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
43
208
2.08
4.83
1.0
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
134
900
1.50
4.79
1.2
1.2
u/ml
15.9
45.1
4.73
13
102
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
105
668
1.58
4.79
1.1
1.1
iu/ml
1358.2
897.7
0.11
24
150
(3011397) Hemoglobin [Presence] in Urine by Test strip
1134
10052
1.16
4.74
3.5
3.6
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
58
314
1.86
4.74
1.1
1.1
mg/l
258.0
265.6
0.13
51
267
(3036489) Thrombin time
221
1637
1.37
4.64
1.9
2.1
s
20.8
21.5
1.40
184
1424
(4027681)
48
246
1.96
4.62
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
84
512
1.65
4.57
1.2
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
26
104
2.51
4.53
1.2
1.2
ug/l
320.4
431.6
0.11
13
49
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
52
276
1.89
4.53
1.7
1.5
u/l
4.2
6.0
0.56
30
134
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
109
712
1.54
4.46
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
84
516
1.64
4.45
1.6
1.5
%
58.0
58.2
0.02
57
312
(4062490)
75
448
1.68
4.42
1.4
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
186
1351
1.39
4.42
2.1
2.2
%
92.8
91.6
0.32
175
1261
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
64
366
1.76
4.40
1.3
1.5
ug/l
2.2
3.9
1.38
54
304
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
182
1318
1.39
4.40
1.5
1.6
iu/ml
0.1
7.8
0.94
46
280
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
128
871
1.48
4.33
5.3
5.7
iu/ml
221.2
2333.9
—
10
128
(3017732) Neutrophils [#/volume] in Blood
371
2982
1.26
4.33
3.0
3.0
e9/l
4.3
4.1
0.64
285
2333
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
143
996
1.45
4.30
1.3
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
34
158
2.16
4.26
1.1
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
124
842
1.48
4.25
1.2
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
83
516
1.62
4.21
1.9
1.9
ug/l
36.0
22.1
0.45
83
509
(3024139) IgG subclass 3 [Mass/volume] in Serum
74
448
1.66
4.17
1.4
1.4
g/l
0.3
0.4
1.46
47
314
(3028192) IgG subclass 2 [Mass/volume] in Serum
74
448
1.66
4.17
1.4
1.4
g/l
2.9
2.9
0.04
46
314
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
47
249
1.90
4.15
1.1
1.1
u/l
1.2
1.1
0.22
21
128
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
30
134
2.25
4.14
1.1
1.2
%
86.7
88.7
0.09
15
69
(3027135) IgG subclass 1 [Mass/volume] in Serum
74
449
1.66
4.14
1.4
1.4
g/l
6.5
7.0
0.50
46
313
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
125
856
1.47
4.12
1.5
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
24
97
2.48
4.12
1.3
1.4
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
30
135
2.23
4.08
1.1
1.1
%
85.6
88.7
0.21
15
69
(3026389) Candida sp identified in Specimen by Organism specific culture
92
592
1.56
4.06
1.5
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
113
761
1.50
4.05
1.7
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
49
266
1.85
4.02
1.1
1.1
nmol/l
7.1
11.8
0.26
14
58
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
44
231
1.91
4.00
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
66
393
1.69
3.97
1.5
1.5
%
39.4
32.6
0.69
45
232
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
68
410
1.67
3.91
4.7
4.8
u/ml
299.8
68.5
0.76
22
117
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
135
949
1.43
3.90
3.1
3.3
u/ml
1065.9
635.0
0.18
123
869
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
41
212
1.94
3.90
4.0
4.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
38
3.43
3.90
1.1
1.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
17
59
2.89
3.89
1.4
1.4
nmol/l
7.2
542863.8
—
9
49
(3011288) Drugs identified in Urine by Screen method
120
826
1.46
3.88
2.3
3.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
145
1035
1.41
3.86
4.4
4.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
158
1145
1.39
3.85
1.3
1.3
u/ml
10.8
7.0
0.27
24
186
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
122
847
1.45
3.78
2.0
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
158
1150
1.39
3.76
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
41
215
1.91
3.76
1.3
1.3
nmol/l
133.5
133.9
0.02
41
215
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
142
1017
1.41
3.72
2.2
2.4
ug/min
208.9
95.4
0.79
74
617
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
58
340
1.71
3.72
1.2
1.2
titre
80.0
146.1
—
7
69
(3008116) Ketones [Moles/volume] in Urine by Test strip
21
84
2.51
3.70
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
110
754
1.47
3.65
1.5
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
86
560
1.54
3.64
1.6
1.5
—
—
—
0
0
(4306422)
98
657
1.50
3.63
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
155
1132
1.38
3.63
1.3
1.3
u/ml
2.3
5.8
0.66
19
111
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
114
790
1.45
3.59
1.2
1.2
u/ml
242.7
282.6
0.76
72
498
(3023419) Bacteria identified in Sputum by Culture
88
579
1.53
3.56
2.6
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
77
492
1.57
3.55
2.4
2.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
37
192
1.93
3.52
1.0
1.2
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
9
17
5.30
3.50
1.7
1.5
nmol/l
1.4
1.7
—
9
17
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
6
10.01
3.49
3.2
9.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
57
340
1.68
3.46
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
57
340
1.68
3.46
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
185
1402
1.33
3.44
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
57
341
1.68
3.42
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
65
403
1.62
3.41
3.5
2.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
80
522
1.54
3.38
1.1
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
10
27
3.71
3.35
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3743
36236
1.12
3.34
26.0
18.3
g/l
331.3
332.2
8.75
3728
35991
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
57
344
1.66
3.32
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
57
344
1.66
3.32
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
57
344
1.66
3.32
1.2
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
21
89
2.37
3.31
1.2
1.2
%
59.2
78.4
—
5
25
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
20
83
2.42
3.30
1.1
1.1
pmol/l
—
6.4
—
0
11
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
145
1066
1.37
3.30
1.5
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
84
558
1.51
3.28
1.4
3.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
83
550
1.52
3.28
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
304
3715
0.81
3.28
1.3
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
187
2416
0.77
3.22
1.5
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
16
60
2.67
3.22
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
163
1229
1.34
3.16
1.5
2.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
35
186
1.89
3.14
1.9
2.3
umol/l
83.6
151.8
1.51
18
102
(3006922) Hepatitis E virus Ab [Presence] in Serum
51
304
1.68
3.13
1.1
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
19
79
2.41
3.13
1.1
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
61
2.63
3.13
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
109
772
1.42
3.10
1.7
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
163
1233
1.33
3.10
1.5
2.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
36
194
1.86
3.10
2.1
2.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
152
1139
1.34
3.08
1.5
2.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
60
375
1.61
3.08
1.3
1.4
u/l
248.2
330.8
1.37
54
362
(3014765) Yersinia sp identified in Stool by Organism specific culture
165
1252
1.33
3.08
1.1
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
55
337
1.64
3.05
1.3
1.3
mmol/l
11.4
11.9
0.19
18
86
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
126
918
1.38
3.05
1.2
1.2
u/ml
2.4
5.4
—
8
67
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
22
99
2.23
3.05
1.1
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
56
2.68
3.05
1.1
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
73
479
1.53
3.05
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
107
759
1.42
3.03
1.3
1.4
u/ml
114.2
115.1
0.03
19
154
(3028300) Cannabinoids [Presence] in Urine
163
1240
1.32
3.00
1.5
2.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
82
554
1.49
2.99
1.6
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
41
233
1.77
2.99
1.3
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
14
51
2.75
2.98
1.1
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
39
219
1.79
2.96
1.8
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
39
219
1.79
2.96
1.8
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
39
219
1.79
2.96
1.8
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
39
219
1.79
2.96
1.8
2.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
26
127
2.05
2.96
1.1
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
57
2.64
2.96
1.2
1.2
%
39.3
58.3
—
9
24
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
87
597
1.47
2.94
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
81
548
1.49
2.94
1.6
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
61
388
1.58
2.93
1.2
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
20
88
2.28
2.93
1.2
1.2
%
92.3
81.5
—
6
26
(3048929) Epstein Barr virus Ab [Presence] in Serum
158
1203
1.32
2.90
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
301
3632
0.82
2.90
1.8
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
45
266
1.70
2.88
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
162
1240
1.32
2.87
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
80
544
1.48
2.85
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
164
1260
1.31
2.83
1.1
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
80
545
1.48
2.82
1.6
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
24
116
2.07
2.82
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
25
123
2.04
2.81
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
123
2.04
2.81
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
91
637
1.44
2.80
1.1
1.1
%
122.8
117.0
0.98
77
570
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
17
71
2.40
2.79
1.4
2.0
umol/l
18.7
17.2
0.18
17
71
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
8
18
4.45
2.79
5.9
5.0
umol/l
590.8
374.8
—
8
18
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
77
524
1.48
2.74
2.6
2.2
mg/l
25.2
22.8
0.16
23
136
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
58
371
1.57
2.74
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
256
2092
1.24
2.69
1.7
1.9
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
47
287
1.64
2.68
1.1
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
59
381
1.55
2.68
1.7
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
59
381
1.55
2.68
1.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
59
381
1.55
2.68
1.7
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
62
405
1.54
2.68
1.2
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
41
242
1.70
2.66
2.9
2.7
ph
7.4
7.4
0.65
18
88
(1001926) Buprenorphine [Presence] in Urine by Screen method
128
959
1.34
2.65
1.5
2.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
43
258
1.67
2.63
4.1
3.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
13
49
2.66
2.62
1.1
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
13
49
2.66
2.62
1.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
66
440
1.51
2.61
3.8
3.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
127
1.97
2.59
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
112
826
1.36
2.57
1.2
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
9
25
3.60
2.57
7.3
4.9
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
12
44
2.73
2.54
1.4
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
6
11
5.46
2.54
1.3
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
83
583
1.43
2.54
1.1
1.1
g/l
1.5
1.5
0.01
77
523
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
46
286
1.61
2.47
1.1
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
393
3376
1.18
2.46
1.9
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
155
1210
1.29
2.43
1.5
2.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
27
145
1.87
2.41
2.0
2.6
umol/l
29.9
30.1
0.04
21
102
(3000475) Leukocytes [#/volume] in Synovial fluid
135
1036
1.31
2.40
2.0
1.6
e6/l
13319.4
11398.5
0.27
96
735
(3022689) Creatine [Moles/volume] in Urine
25
131
1.91
2.40
1.8
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
146
1133
1.30
2.39
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
75
524
1.44
2.38
1.3
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
27
146
1.85
2.36
1.2
1.3
g/l
0.3
0.3
1.38
20
115
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
25
132
1.90
2.35
1.8
1.5
ug/l
10.0
8.7
0.64
25
132
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
140
1085
1.30
2.33
1.1
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
10
35
2.86
2.30
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
129
991
1.31
2.29
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
91
663
1.38
2.29
1.1
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
59
2.38
2.29
12.1
13.4
mmol/l
5.5
5.8
0.19
14
59
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
95
698
1.37
2.28
1.1
1.1
—
—
—
0
0
(4268621)
67
463
1.45
2.27
2.8
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
102
759
1.35
2.26
1.3
1.3
—
—
—
0
0
(4198724)
26
142
1.84
2.22
1.2
3.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
33
194
1.71
2.22
1.2
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
29
165
1.76
2.18
1.5
1.4
—
1352887.5
—
0
12
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
31
180
1.73
2.18
1.1
1.1
ng/l
161.9
439.5
—
7
43
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
93
687
1.36
2.17
1.4
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
78
560
1.40
2.16
1.6
1.5
g/l
33.0
32.6
0.11
69
508
(3043410) Blood group antigens tested for on Red Blood Cells
22
115
1.92
2.15
2.4
1.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
29
166
1.75
2.14
1.1
1.1
miu/ml
1083.0
1535.4
1.39
29
166
(40768443) Skin Pathology biopsy report
230
1909
1.21
2.14
1.2
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
16
74
2.17
2.14
1.9
2.7
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
37
227
1.63
2.14
1.2
1.1
u/l
31.7
28.2
0.09
27
169
(3011648) Oxygen content in Venous blood
53
354
1.50
2.14
1.9
2.4
%
11.2
11.0
0.07
53
354
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
432
3788
1.15
2.11
2.0
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
76
546
1.40
2.11
1.8
1.7
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
37
228
1.63
2.10
1.2
1.1
u/l
99.6
88.2
0.22
28
174
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
49
2.45
2.10
1.2
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
10
37
2.71
2.10
2.8
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
134
1050
1.28
2.08
1.5
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
16
75
2.14
2.08
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
55
373
1.48
2.07
1.2
1.2
nmol/l
334.9
367.8
0.53
45
327
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
167
1348
1.25
2.04
1.6
1.8
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
57
391
1.46
2.03
1.4
1.3
nmol/l
1.4
1.5
0.21
50
355
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
56
383
1.47
2.03
1.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
10
38
2.63
2.01
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
105
801
1.32
2.00
1.8
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
25
140
1.79
2.00
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
43
280
1.54
1.97
1.4
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
51
345
1.48
1.96
1.1
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
18
91
1.98
1.94
2.2
2.0
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
18
91
1.98
1.94
2.2
3.3
ng/l
119.9
146.9
0.18
11
44
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
61
429
1.43
1.93
3.3
3.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
26
150
1.74
1.90
1.3
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
36
227
1.59
1.90
1.4
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
69
498
1.39
1.89
1.6
1.5
e6/l
1271.3
2203.1
1.30
53
358
(46235168) Fasting glucose [Moles/volume] in Blood
0
51
0.00
1.88
0.0
1.4
—
7.8
—
0
23
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
60
423
1.42
1.88
1.3
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
80
593
1.35
1.87
5.3
5.2
umol/l
366.6
362.1
0.11
74
516
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
102
784
1.31
1.87
1.4
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
63
449
1.41
1.86
2.4
2.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
34
2.65
1.86
1.2
1.2
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
5
12
4.17
1.82
1.2
1.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
19
101
1.88
1.80
1.6
1.4
%
22.6
22.3
0.01
14
82
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
598
5419
1.12
1.78
4.8
4.5
%
31.5
32.4
1.14
442
3645
(3017704) Immunofixation for Urine
36
231
1.56
1.78
2.1
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
41
272
1.51
1.76
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
142
1149
1.24
1.74
1.2
1.3
miu/ml
212.2
210.2
0.02
48
530
(4015189)
20
110
1.82
1.72
2.4
2.3
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
13
61
2.13
1.71
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
133
1072
1.25
1.70
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
41
275
1.49
1.68
1.5
1.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
22
126
1.75
1.67
1.3
1.2
g/l
36.6
38.7
0.25
16
62
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
197
1658
1.20
1.66
1.6
1.8
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
25
2.80
1.65
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
523
4730
1.12
1.63
1.7
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
89
687
1.30
1.62
1.4
1.2
u/ml
1.9
3.9
1.83
27
216
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
26
158
1.65
1.62
1.5
1.5
%
64.0
64.5
0.02
21
128
(40768806) Pleura Pathology biopsy report
62
454
1.37
1.61
1.8
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
771
7121
1.10
1.60
1.6
1.5
—
—
—
0
0
(4146454)
63
463
1.37
1.60
2.7
2.7
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
31
198
1.57
1.59
1.1
1.1
%
102.8
94.2
0.53
20
150
(3029075) Extractable nuclear Ab panel - Serum
21
121
1.74
1.58
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
90
699
1.29
1.57
1.8
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
251
2169
1.17
1.56
3.9
3.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
46
322
1.43
1.55
1.2
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
44
306
1.44
1.53
1.0
1.0
ng/l
818.8
732.7
0.52
33
202
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
220
0.50
1.53
1.3
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
40
273
1.47
1.53
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
110
881
1.25
1.52
3.3
3.7
%
58.6
57.7
0.30
110
881
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
250
2166
1.16
1.51
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
60
443
1.36
1.50
1.8
1.8
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
44
308
1.43
1.49
1.0
1.0
ng/l
33.0
45.0
1.71
32
203
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
58
2.07
1.49
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
47
334
1.41
1.47
1.4
1.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
21
124
1.70
1.46
1.9
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
233
2015
1.16
1.45
2.0
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
89
699
1.28
1.45
1.2
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
44
310
1.42
1.45
1.7
1.8
mmol/l
6.4
6.6
0.35
29
206
(3039443) Prostate specific Ag panel - Serum or Plasma
59
787
0.75
1.44
1.6
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
76
585
1.30
1.44
1.1
1.0
u/ml
6.6
3.1
0.61
38
256
(3036071) Salmonella sp Ab [Titer] in Serum
23
140
1.65
1.44
1.0
1.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
38
261
1.46
1.43
1.1
1.1
ratio
1.1
1.0
—
7
93
(44806118)
66
499
1.33
1.42
1.4
1.4
—
—
—
0
0
(44790047)
66
499
1.33
1.42
1.4
1.4
—
—
—
0
0
(44790048)
66
499
1.33
1.42
1.4
1.4
—
—
—
0
0
(44790049)
66
499
1.33
1.42
1.4
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
27
173
1.56
1.39
1.8
1.6
—
—
—
0
0
(3025315) Body weight
7
29
2.42
1.39
6.0
4.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
255
1.45
1.37
1.3
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
61
459
1.33
1.37
13.5
5.2
mmol/l
7.7
7.2
0.28
52
381
(3028717) Thiamine [Mass/volume] in Blood
9
41
2.20
1.37
1.4
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
23
2.61
1.36
1.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
43
306
1.41
1.35
1.0
1.0
ng/l
255.9
327.9
1.51
33
206
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
59
443
1.34
1.35
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
237
2067
1.15
1.34
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
63
478
1.32
1.34
1.7
1.7
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
17
97
1.76
1.34
1.0
1.2
—
260.0
—
0
6
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
37
257
1.44
1.33
1.3
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
98
790
1.25
1.31
1.5
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
347
3111
1.12
1.30
1.6
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
46
334
1.38
1.30
1.0
1.5
promille
1.2
1.2
0.07
35
259
(44806420)
20
121
1.66
1.30
2.4
2.4
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
34
2.35
1.29
1.6
5.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
39
276
1.42
1.28
1.3
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
19
114
1.67
1.28
1.2
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
15
84
1.79
1.27
1.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
44
319
1.38
1.26
2.7
2.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
44
2.05
1.26
1.1
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
9
44
2.05
1.26
1.3
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
32
219
1.46
1.25
2.3
2.2
ug/min
24.7
286.3
—
9
49
(3028679) Herpes simplex virus Ab [Presence] in Serum
32
219
1.46
1.25
1.1
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
59
449
1.32
1.25
1.7
1.5
e6/l
37299.4
79207.6
0.88
38
260
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
25
2.40
1.24
1.2
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
30
203
1.48
1.24
1.6
1.4
%
1.2
3.7
—
5
41
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
39
279
1.40
1.22
1.3
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
45
330
1.37
1.22
2.7
2.1
%
10.6
14.0
1.14
17
144
(3014891) Appearance of Pleural fluid
11
56
1.97
1.22
2.1
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
20
124
1.62
1.20
3.3
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
20
124
1.62
1.20
3.3
2.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
56
426
1.32
1.20
3.3
2.4
e9/l
1.0
1.1
0.40
33
260
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
77
612
1.26
1.19
1.3
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
97
792
1.23
1.19
3.4
3.1
nmol/l
0.8
0.8
0.01
76
597
(3004775) Volume in Urine collected for unspecified duration
45
333
1.35
1.16
2.1
2.3
ml
731.8
635.1
0.74
30
221
(3039744) RNA polymerase III Ab [Units/volume] in Serum
8
39
2.05
1.15
1.0
1.1
—
3.8
—
0
7
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
20
2.50
1.15
1.0
1.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
18
110
1.64
1.15
2.1
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
26
174
1.50
1.15
2.0
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
26
174
1.50
1.15
2.0
2.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
111
923
1.21
1.15
3.7
3.4
mg/l
28.5
28.3
0.02
68
562
(3012441) Differential panel - Pleural fluid
56
430
1.31
1.14
1.6
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
27
183
1.48
1.13
3.2
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
26
176
1.48
1.10
2.0
2.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
112
1331
0.84
1.08
1.6
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
32
2.19
1.08
2.7
2.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
42
312
1.35
1.08
3.4
2.4
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
7
33
2.12
1.05
1.0
1.1
—
5.3
—
0
7
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
19
121
1.57
1.05
1.4
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
82
669
1.23
1.04
1.4
1.2
u/ml
8.3
4.4
0.64
40
281
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
22
2.27
1.03
7.2
11.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
52
402
1.30
1.03
1.5
1.3
e6/l
112969.0
88818.3
0.08
35
276
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
29
204
1.42
1.02
1.6
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
29
204
1.42
1.02
1.6
1.4
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
19
122
1.56
1.02
1.7
1.5
%
21.9
23.3
0.08
19
112
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
35
255
1.38
1.02
1.3
1.4
—
—
—
0
0
(4024509)
56
438
1.28
1.02
1.5
1.6
—
—
—
0
0
(4281824)
61
483
1.27
1.01
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
290
1.35
1.01
1.3
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
51
652
0.78
0.99
1.4
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
30
214
1.40
0.99
1.1
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
51
397
1.29
0.97
1.6
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
92
1.63
0.97
1.2
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
35
258
1.36
0.96
1.1
1.3
titre
94.0
65.2
—
5
23
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
50
1.80
0.96
1.2
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
9
51
1.77
0.94
1.0
1.1
—
7.7
—
0
8
(3044009) aPTT.lupus sensitive (LA screen)
7
37
1.89
0.94
1.1
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
27
2.22
0.93
1.7
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
116
1352
0.85
0.93
1.5
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
12
70
1.72
0.92
4.1
6.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
201
1.40
0.91
3.3
3.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
159
1.45
0.91
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
23
159
1.45
0.91
1.4
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
18
118
1.53
0.90
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
15
94
1.60
0.90
2.5
2.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
30
219
1.37
0.89
1.2
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
30
219
1.37
0.89
1.2
1.6
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
20
135
1.48
0.89
1.7
1.5
%
2.5
3.0
0.08
20
115
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
12
71
1.69
0.88
1.2
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
168
0.59
0.86
1.2
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
28
204
1.37
0.85
1.4
1.5
mmol/l
8.5
7.9
0.41
12
123
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
33
248
1.33
0.83
2.0
2.1
min
525.4
489.8
1.04
23
184
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
55
443
1.24
0.83
1.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
113
1.51
0.82
1.2
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
32
1.88
0.81
2.7
3.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
22
155
1.42
0.81
1.3
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
13
82
1.59
0.78
1.2
1.3
—
103.0
—
0
16
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
23
165
1.40
0.77
1.0
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
26
191
1.36
0.76
3.3
2.0
%
4.8
8.8
2.06
26
183
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
20
140
1.43
0.76
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
33
252
1.31
0.76
1.1
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
12
75
1.60
0.74
1.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
24
2.08
0.74
1.0
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
24
2.08
0.74
3.2
3.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
133
1.43
0.73
1.6
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
19
133
1.43
0.73
1.1
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
16
108
1.48
0.73
1.0
1.1
u/ml
0.2
1.9
1.09
11
50
(3005082) Progesterone [Moles/volume] in Serum or Plasma
8
133
0.60
0.73
1.3
1.3
nmol/l
16.3
31.8
—
8
111
(3004616) Nuclear Ab [Presence] in Serum
64
533
1.20
0.73
1.4
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
61
506
1.21
0.72
1.3
1.6
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
25
2.00
0.72
1.2
1.5
umol/24h
347.0
373.7
—
5
25
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
37
290
1.28
0.72
3.1
2.5
e6/l
656.1
523.5
0.46
29
246
(40768795) Lymph node Pathology biopsy report
54
443
1.22
0.72
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
25
185
1.35
0.71
2.4
2.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
12
76
1.58
0.71
1.1
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
7
40
1.75
0.71
1.1
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
26
1.92
0.70
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
26
1.92
0.70
1.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
74
628
1.18
0.70
1.4
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1556
15117
1.04
0.70
3.1
2.8
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
58
1.55
0.69
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
143
0.63
0.69
3.4
1.8
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
110
1.46
0.68
9.2
7.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
39
484
0.80
0.66
1.3
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
35
277
1.27
0.65
3.3
2.6
e9/l
0.3
0.2
0.51
28
243
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
34
269
1.27
0.63
1.1
1.1
iu/ml
3.7
11.0
—
7
74
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
20
146
1.37
0.63
1.1
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
51
423
1.21
0.63
3.3
3.1
mg/l
194.7
40.1
0.82
37
315
(40762365) Oxygen content in Arterial blood by calculation
12
79
1.52
0.62
1.4
2.6
ml/dl
17.0
14.9
2.03
12
74
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
36
288
1.25
0.62
1.6
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
63
1.59
0.61
1.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
48
397
1.21
0.61
2.2
2.1
umol/l
10.6
6.7
0.54
37
275
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
44
361
1.22
0.61
1.3
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
950
9161
1.05
0.61
4.2
4.1
kg/l
1.0
1.0
0.08
145
1342
(3050129) First trimester maternal screen panel - Serum or Plasma
74
854
0.86
0.59
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
55
464
1.19
0.58
2.3
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
13
89
1.46
0.58
3.1
2.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
13
89
1.46
0.58
1.3
1.6
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
35
1.72
0.57
1.2
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
212
1.28
0.55
1.9
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
653
6808
0.95
0.55
1.5
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
10
66
1.52
0.52
1.4
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
62
536
1.16
0.51
1.3
1.3
mmol/l
7.7
7.4
0.26
46
398
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
45
1.56
0.49
2.1
2.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
79
699
1.13
0.48
1.5
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
37
308
1.20
0.48
1.2
1.3
u/ml
0.4
0.9
0.64
19
138
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
47
1.49
0.47
1.3
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
48
1.46
0.46
2.1
2.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
30
246
1.22
0.45
1.2
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
50
1.40
0.45
1.1
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
53
459
1.16
0.45
1.4
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
43
367
1.17
0.43
3.0
2.3
%
36.1
41.4
—
7
41
(3003888) Timothy IgE Ab [Units/volume] in Serum
73
650
1.12
0.42
1.0
1.1
u/ml
5.8
4.9
0.12
34
327
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
32
1.56
0.42
1.6
2.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
17
131
1.30
0.42
4.5
3.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
376
3589
1.05
0.41
1.4
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
33
1.52
0.41
6.4
5.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
2.3
—
0
15
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.2
—
45.2
—
0
10
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
27
222
1.22
0.41
1.2
1.7
u/field
1.5
3.0
0.77
18
157
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
88
1.36
0.40
1.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
334
1.17
0.39
2.6
2.0
u/field
0.8
1.9
2.28
17
133
(4133840)
7
104
0.67
0.39
1.6
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
35
1.43
0.39
1.4
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
10.4
—
0
19
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
48
419
1.15
0.38
1.0
1.1
u/ml
0.4
0.3
—
10
102
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
89
1.35
0.37
1.3
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
23
188
1.22
0.37
2.0
1.6
umol/l
31.4
29.4
0.34
23
180
(3025577) Chromium [Mass/volume] in Blood
23
279
0.82
0.37
1.7
2.1
ug/l
1.4
2.2
1.75
18
236
(40758292) HTLV I+II Ab panel - Serum
9
69
1.30
0.37
1.2
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
152
1.25
0.37
3.7
1.9
—
—
—
0
0
(4034850)
153
1427
1.07
0.37
8.8
9.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
116
0.69
0.36
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
65
582
1.12
0.36
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
52
459
1.13
0.36
1.0
1.1
u/ml
2.0
3.5
1.05
17
180
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
71
1.27
0.36
1.0
1.9
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
13
99
1.31
0.35
2.1
1.8
ug/l
3.5
2.0
—
8
52
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
26
307
0.85
0.33
3.6
2.5
e6/l
683.1
658.0
0.12
16
127
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
182
1.21
0.33
1.2
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
298
2857
1.05
0.30
3.2
3.0
—
—
—
0
0
(44806071)
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
62
682
0.91
0.29
1.4
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
96
1034
0.93
0.29
1.4
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.1
1.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
109
0.73
0.29
1.6
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
372
3592
1.04
0.28
3.7
3.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
94
1.28
0.28
1.1
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
145
1535
0.94
0.27
1.5
1.7
mg/l
4.2
3.8
0.15
107
1090
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
52
573
0.91
0.26
1.5
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
144
1362
1.06
0.26
1.6
1.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
12
95
1.26
0.26
1.2
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
17
141
1.21
0.26
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
28
244
1.15
0.25
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
22
188
1.17
0.25
13.5
11.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
64
588
1.09
0.25
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
63
685
0.92
0.25
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
63
685
0.92
0.25
1.4
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
114
1.23
0.25
1.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
63
684
0.92
0.24
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
69
746
0.92
0.24
1.5
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
96
1.25
0.24
9.1
7.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
68
628
1.08
0.24
1.0
1.1
u/ml
2.0
1.2
0.30
28
262
(3020874) Milk IgE Ab [Units/volume] in Serum
25
217
1.15
0.24
1.0
1.0
u/ml
0.1
3.1
—
5
67
(3002523) Influenza virus A Ag [Presence] in Specimen
66
609
1.08
0.24
1.1
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
32
284
1.13
0.23
1.5
1.4
pmol/l
52.0
162.1
0.59
19
96
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
134
1.19
0.22
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
17
200
0.85
0.22
1.1
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
88
1.25
0.22
1.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
5
40
1.25
0.22
1.2
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
17
144
1.18
0.22
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
555
5427
1.03
0.21
8.3
6.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
13
107
1.22
0.21
1.1
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
43
1.16
0.21
2.0
2.0
—
—
—
0
0
(4212803)
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
11541.6
—
0
5
(3002619) Bacteria identified in Specimen by Culture
10
80
1.25
0.20
1.3
1.2
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
3.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
21
183
1.15
0.20
1.2
1.1
iu/ml
211.8
181.9
0.19
21
183
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
26
292
0.89
0.20
1.2
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
50
1.20
0.19
12.5
11.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
37
336
1.10
0.19
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
63
587
1.07
0.19
1.0
1.1
u/ml
0.7
1.8
1.65
14
135
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
53
1.13
0.18
1.2
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
14
119
1.18
0.17
1.2
1.4
nmol/l
75.8
129.8
—
9
89
(3014133) Dog dander IgE Ab [Units/volume] in Serum
54
503
1.07
0.17
1.0
1.1
u/ml
1.3
2.6
0.99
19
186
(3003740) Influenza virus B Ag [Presence] in Specimen
65
610
1.07
0.17
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
45
416
1.08
0.17
1.2
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
62
1.13
0.17
1.4
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
62
1.13
0.17
1.4
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
62
1.13
0.17
1.4
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
62
1.13
0.17
1.1
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
131
0.84
0.17
2.9
2.1
—
—
—
0
0
(4094501)
126
1209
1.04
0.16
1.1
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
55
515
1.07
0.16
3.0
2.8
%
13.4
13.2
0.73
55
508
(3001019) Free T4 and TSH panel - Serum or Plasma
207
2134
0.97
0.16
1.7
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
16
140
1.14
0.15
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
26
236
1.10
0.14
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
129
0.85
0.14
1.1
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
138
0.87
0.13
1.9
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
161
1.12
0.13
1.1
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
55
579
0.95
0.12
1.5
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
18
162
1.11
0.11
1.2
3.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
143
1.12
0.11
5.9
4.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
34
363
0.94
0.11
1.0
1.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
27
250
1.08
0.11
2.4
2.6
%
45.8
40.2
0.69
14
84
(3014051) Protein [Presence] in Urine by Test strip
101
1044
0.97
0.10
2.2
2.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
45
1.11
0.09
1.4
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
10
87
1.15
0.09
1.0
1.2
mg/l
0.4
81.6
—
5
62
(3047352) Trisomy 18 risk [Likelihood] in Fetus
54
564
0.96
0.09
1.4
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
72
695
1.04
0.08
1.3
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
107
1.12
0.08
1.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
61
0.82
0.08
1.8
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
54
561
0.96
0.07
1.4
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
76
1.05
0.07
7.6
7.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
80
0.87
0.07
1.7
1.6
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
11
121
0.91
0.06
3.7
2.8
—
96.9
—
0
20
(3033799) Differential panel - Peritoneal fluid
13
141
0.92
0.05
2.7
2.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
12
110
1.09
0.05
2.2
1.7
mmol/l
1.7
0.9
0.28
12
103
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
147
1450
1.01
0.04
1.4
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
18
170
1.06
0.04
1.9
1.9
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
19
180
1.06
0.04
1.5
2.0
ug/l
18.6
65.4
0.56
19
164
(4211845)
22
229
0.96
0.02
4.0
3.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
163
1.04
0.01
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
24
234
1.03
0.00
1.6
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
185
1.03
0.00
1.3
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
74
735
1.01
0.00
1.1
1.1
u/ml
1.0
1.6
0.57
26
284
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
26
263
0.99
0.00
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
33
333
0.99
0.00
1.4
1.5
g/l
1.0
1.0
0.42
33
333
(3013637) Mi-2 Ab [Presence] in Serum
11
109
1.01
0.00
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
109
1.01
0.00
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
109
1.01
0.00
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
109
1.01
0.00
1.2
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
21
211
1.00
0.00
4.1
3.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
21
211
1.00
0.00
1.2
1.2
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
65
0.92
0.00
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
68
0.88
0.00
3.8
5.4
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(3041806) Other cells [#/volume] in Blood by Manual count
8
86
0.93
0.00
1.0
1.6
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.3
—
158.3
—
0
7
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
119.3
—
0
7
(3007919) Fasciola sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
29
290
1.00
0.00
1.2
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
2.5
3.8
umol/l
27.3
42.8
—
6
48
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
50
1.00
0.00
2.6
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_ENDOCRINE_OTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ENDOCRINE_OTH | 1.509 [1.35, 1.69] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.134 |
During the follow-up period (1.1.1998 — 31.12.2019), 1632 out of 11377 females with CD2_BENIGN_ENDOCRINE_OTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ENDOCRINE_OTH | 1.447 [1.28, 1.63] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1537 out of 7702 males with CD2_BENIGN_ENDOCRINE_OTH died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_ENDOCRINE_OTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.12% | 0.273% |
| 5 | 0.818% | 1.473% |
| 10 | 2.041% | 3.653% |
| 15 | 4.03% | 6.922% |
| 20 | 6.935% | 11.57% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ENDOCRINE_OTH – Benign neoplasm of other and unspecified endocrine glands
GWS hits: 5
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data